958 results on '"David K. Stevenson"'
Search Results
202. Hyperbilirubinemia and Kernicterus
- Author
-
David K. Stevenson, Ronald J. Wong, and Phyllis A. Dennery
- Published
- 2017
203. Prediction of preterm birth with and without preeclampsia using mid-pregnancy immune and growth-related molecular factors and maternal characteristics
- Author
-
Laura L, Jelliffe-Pawlowski, Larry, Rand, Bruce, Bedell, Rebecca J, Baer, Scott P, Oltman, Mary E, Norton, Gary M, Shaw, David K, Stevenson, Jeffrey C, Murray, and Kelli K, Ryckman
- Subjects
Adult ,Adolescent ,Gestational Age ,Risk Assessment ,California ,Cohort Studies ,Pregnancy Complications ,Pregnancy Trimester, First ,Young Adult ,Logistic Models ,Pre-Eclampsia ,ROC Curve ,Pregnancy ,Risk Factors ,Pregnancy Trimester, Second ,Humans ,Premature Birth ,Female ,Poverty ,Biomarkers ,Maternal Age - Abstract
To evaluate if mid-pregnancy immune and growth-related molecular factors predict preterm birth (PTB) with and without (±) preeclampsia.Included were 400 women with singleton deliveries in California in 2009-2010 (200 PTB and 200 term) divided into training and testing samples at a 2:1 ratio. Sixty-three markers were tested in 15-20 serum samples using multiplex technology. Linear discriminate analysis was used to create a discriminate function. Model performance was assessed using area under the receiver operating characteristic curve (AUC).Twenty-five serum biomarkers along with maternal age34 years and poverty status identified80% of women with PTB ± preeclampsia with best performance in women with preterm preeclampsia (AUC = 0.889, 95% confidence interval (0.822-0.959) training; 0.883 (0.804-0.963) testing).Together with maternal age and poverty status, mid-pregnancy immune and growth factors reliably identified most women who went on to have a PTB ± preeclampsia.
- Published
- 2017
204. Identification of risk for neonatal haemolysis
- Author
-
Janelle L. Aby, Debra L. Bogen, M. Jeffrey Maisels, David K. Stevenson, Robert D. Christensen, Ronald J. Wong, Jon F. Watchko, Vinod K. Bhutani, Martin E. Castillo Cuadrado, and David L. Schutzman
- Subjects
Male ,medicine.medical_specialty ,Percentile ,Bilirubin ,Combined use ,Gestational Age ,Gastroenterology ,Hemolysis ,Risk Assessment ,Cohort Studies ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Neonatal Screening ,Predictive Value of Tests ,030225 pediatrics ,Internal medicine ,medicine ,Tidal Volume ,Humans ,030212 general & internal medicine ,Prospective Studies ,Analysis of Variance ,Carbon Monoxide ,Transcutaneous bilirubin ,Newborn jaundice ,business.industry ,Infant, Newborn ,General Medicine ,Phototherapy ,Haemolysis ,Treatment Outcome ,chemistry ,Pediatrics, Perinatology and Child Health ,Female ,Hyperbilirubinemia, Neonatal ,Breath carbon monoxide ,business ,Nurseries, Infant ,Rate of rise - Abstract
AIM To identify neonates at risk of haemolytic hyperbilirubinaemia through near-concurrent measurements of total serum/plasma bilirubin (TB) or transcutaneous bilirubin (TcB) and end-tidal breath carbon monoxide (CO), corrected for ambient CO (ETCOc), an index of bilirubin production and haemolysis. METHODS Paired TB/TcB (mg/dL) and ETCOc (ppm) measurements were obtained in newborns (n = 283) at 20 to
- Published
- 2017
205. Neurodevelopmental and Behavioral Outcomes in Extremely Premature Neonates With Ventriculomegaly in the Absence of Periventricular-Intraventricular Hemorrhage
- Author
-
Heike M. Minnich, Ivan D. Frantz, Karen J. Johnson, William E Truog, Sandra Brown, Ronnie Guillet, Myriam Peralta-Carcelen, Rosemary D. Higgins, Haresh Kirpalani, Kathryn E. Gustafson, Leslie Dawn Wilson, Gregory M Sokol, Catherine Twell Boatman, Edward F. Bell, Janet S. Morgan, W. Kenneth Poole, Amanda D. Soong, Jeanette O'Donnell Auman, Avroy A. Fanaroff, Katrina Burson, Gulgun Yalcinkaya, Monica Konstantino, Leif D. Nelin, Bradley A. Yoder, Carin Kiser, Kristin M. Basso, Marian M. Adams, Neil N. Finer, Dennis Wallace, Hali E. Weiss, Deanna Maffett, Hallam Hurt, Fred J. Biasini, Meena Garg, Laura Cole, Kathleen A. Kennedy, Julianne Hunn, Lucy Miller, Anne Holmes, Farooq Osman, Barbara Schmidt, Anna Marie Hibbs, Walid A. Salhab, Karen A. Osborne, M. Bethany Ball, Laura A. Goldston, Silvia M. Frade Eguaras, Faithe Hamer, Julie Babish Johnson, Ruth Everett-Thomas, Patti L. Pierce Tate, Maria Calejo, Michele C. Walsh, Eugenia K. Pallotto, Rachel Geller, Roger G. Faix, Melissa H. Leps, Maria Elena DeAnda, Ronald N. Goldberg, Marie G. Gantz, Sally Whitley, Nehal A. Parikh, Michelle Harwood Berkowits, Seetha Shankaran, Andrew W. Palmquist, Andrea Halbrook, Kimberlee Weaver-Lewis, Theresa M. Leach, Ira Adams-Chapman, Janice Bernhardt, Sarah Ryan, Maynard Rasmussen, Edward F. Donovan, Diana M. Vasil, Carroll Peterson, Jamie E. Newman, Bonnie E. Stephens, Karen A. Wynn, Myra H. Wyckoff, David P. Carlton, Jody Hessling, Barbara Alexander, Katherine A. Foy, Abbot R. Laptook, Michael Steffen, Sudarshan R. Jadcherla, Suzy Ventura, Raquel Halfond, Ana K. Brussa, Charles R. Rosenfeld, Ellen Waldrep, Peggy Robichaux, Donald J. Goldstein, Monika Bhola, Brenda H. Morris, Clarence Demetrio, Erica Burnell, Brenda B. Poindexter, Martha D. Carlson, Sharon L. Wright, Linda A. Madden, Michael S. Caplan, Isabell B. Purdy, Athina Pappas, Barbara Bentley, Carol Hartenberger, Patricia W. Evans, John A. Widness, Marsha Gerdes, Stephanie Wilson Archer, Kimberly Yolton, Christine G. Butler, Roy J. Heyne, Joanne Williams, Gaynelle Hensley, Carl L. Bose, Lu Ann Papile, Richard A. Polin, Brenda L. MacKinnon, JoAnn Poulsen, Anne Marie Reynolds, T. Michael O'Shea, Charles R. Bauer, Gary J. Myers, Joanne Finkle, Maegan C. Simmons, Shahnaz Duara, Arielle Rigaud, Jill Burnett, Jacky R. Walker, Lauren Zwetsch, Ellen Nylen, Margarita Jiminez, Christine A. Fortney, Angelita M. Hensman, Ellen C. Hale, Joan Merzbach, Teresa L. Gratton, Yvonne E. Vaucher, Kathy Arnell, Holly I.M. Wadkins, Sara Kryzwanski, Nancy A. Miller, Susan R. Hintz, Elaine Romano, Betty R. Vohr, Sara B. DeMauro, Donia B. Campbell, Dara M. Cucinotta, Anna Bodnar, Kristy Domnanovich, Angela Argento, Georgia E. McDavid, Kurt Schibler, Patricia L. Ashley, Margaret M. Crawford, Casey E. Krueger, Bonnie S. Siner, Sally S. Adams, Jane E. Brumbaugh, Korinne Chiu, Janice Wereszczak, Satyanarayana Lakshminrusimha, Jon E. Tyson, Carolyn Lytle, Toni Mancini, Nancy Peters, Gennie Bose, Cryshelle S. Patterson, Katharine Johnson, Barbara J. Stoll, Kristin Kirker, Gail Hounshell, Melinda S. Proud, Janet Taft, Dale L. Phelps, Keith Owen Yeates, Kathy Johnson, Dan L. Ellsbury, Martin Keszler, Leslie Rodrigues, Jennifer J. Jensen, Barbara Alksninis, Sandra Grimes, Wade Rich, Stephanie A. Wiggins, Krisa P. Van Meurs, Yvonne Loggins, M. Layne Poundstone, David Kaegi, Elizabeth T. Heyne, Sheena L. Carter, Patricia Cervone, Richard V. Rector, John M. Fiascone, Nora I. Alaniz, Helina Pierre, Waldemar A. Carlo, Kimberley A. Fisher, Elisabeth C. McGowan, Robert G. Dillard, Greg Muthig, Sarah Martin, Carolyn M. Petrie Huitema, Barbara G. Jackson, Brian G. Tang, Melinda Caskey, Vivien Phillips, Soraya Abbasi, Michael J. Acarregui, Andrea Garcia, Robert T. Burke, Aasma S. Chaudhary, Luc P. Brion, Jean G. Kohn, Kelley Yost, Melody B. Lohmeyer, Allison F. Payne, Harriet Friedman, Victoria E. Watson, William Oh, Nancy S. Newman, John Barks, Andrea H. Duncan, Pablo J. Sánchez, Mary Lenore Keszler, Deborah Evans Allred, Rosemary L. Jensen, Karie Bird, Kristin M. Zaterka-Baxter, Ann B. Cook, Alicia Guzman, Holly L. Mincey, Gail E. Besner, Kate Bridges, Sylvia Fajardo-Hiriart, Matthew M. Laughon, Cathy Grisby, Robin K. Ohls, Rebecca Bara, Karen Zanetti, Anne M. DeBattista, Tarah T. Colaizy, William F. Malcolm, Cherrie D. Welch, Judy Bernbaum, Melissa Whalen Morris, Kathleen G. Nelson, Scott A. McDonald, Emily Kushner, Abbey C. Hines, Sheila Greisman, Ashley Williams, Estelle E. Fischer, Lenora Jackson, Harris C. Jacobs, Cheri Gauldin, Alexandra Stoerger, Deanne E. Wilson-Costello, Rebecca Montman, Monica V. Collins, Mary Christensen, Charles Green, Mary Johnson, David K. Stevenson, Lijun Chen, Cecelia E. Sibley, Lisa K. Washburn, Maureen Mulligan LaRossa, Lizette E. Torres, Kathy J. Auten, Chris Henderson, U. Devaskar, Leigh Ann Smith, Janell Fuller, Diane L. Eastman, Anna E. Lis, Dianne E. Herron, Kristen C. Johnston, Anna M. Dusick, Martha G. Fuller, Anne Furey, Howard W. Kilbride, Jean R. Lowe, Elizabeth F. Bruno, Saba Siddiki, Abhik Das, Linda J. Reubens, Richard A. Ehrenkranz, Namasivayam Ambalavanan, Cynthia Spencer, Ricki F. Goldstein, Lynne C. Huffman, Teresa Chanlaw, Patricia Luzader, Carl T. D'Angio, Diane Hust, Radmila West, Beverly Foley Harris, Sarah Winter, Conra Backstrom Lacy, Shawna Baker, Shirley S. Cosby, C. Michael Cotten, and Kristi L. Watterberg
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Gestational Age ,Infant, Premature, Diseases ,Bayley Scales of Infant Development ,03 medical and health sciences ,0302 clinical medicine ,030225 pediatrics ,medicine ,Humans ,Longitudinal Studies ,Original Investigation ,Cerebral Hemorrhage ,Retrospective Studies ,Ultrasonography ,business.industry ,Cerebral Palsy ,Infant, Newborn ,Gestational age ,Brain ,Gross Motor Function Classification System ,Odds ratio ,medicine.disease ,Prognosis ,Intraventricular hemorrhage ,Bronchopulmonary dysplasia ,Neurodevelopmental Disorders ,Infant, Extremely Premature ,Pediatrics, Perinatology and Child Health ,Necrotizing enterocolitis ,Female ,business ,030217 neurology & neurosurgery ,Ventriculomegaly ,Hydrocephalus - Abstract
Importance Studies of cranial ultrasonography and early childhood outcomes among cohorts of extremely preterm neonates have linked periventricular-intraventricular hemorrhage and cystic periventricular leukomalacia with adverse neurodevelopmental outcomes. However, the association between nonhemorrhagic ventriculomegaly and neurodevelopmental and behavioral outcomes is not fully understood. Objective To characterize the outcomes of extremely preterm neonates younger than 27 weeks’ gestational age who experienced nonhemorrhagic ventriculomegaly that was detected prior to 36 weeks’ postmenstrual age. Design, Setting, and Participants This longitudinal observational study was conducted at 16 centers of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Infants born prior to 27 weeks’ gestational age in any network facility between July 1, 2006, and June 30, 2011, were included if they had a cranial ultrasonogram performed prior to 36 weeks’ postmenstrual age. Comparisons were made between those with ventriculomegaly and those with normal cranial sonograms. Data analysis was completed from August 2013 to August 2017. Main Outcomes and Measures The main outcome was neurodevelopmental impairment, defined as a Bayley Scales of Infant and Toddler Development III cognitive score less than 70, moderate/severe cerebral palsy, a Gross Motor Function Classification System score of level 2 or more, vision impairment, or hearing impairment. Secondary outcomes included Bayley Scales of Infant and Toddler Development III subscores, components of neurodevelopmental impairment, behavioral outcomes, and death/neurodevelopmental impairment. Logistic regression was used to evaluate the association of ventriculomegaly with adverse outcomes while controlling for potentially confounding variables and center differences as a random effect. Linear regression was used similarly for continuous outcomes. Results Of 4193 neonates with ultrasonography data, 300 had nonhemorrhagic ventriculomegaly (7%); 3045 had normal cranial ultrasonograms (73%), 775 had periventricular-intraventricular hemorrhage (18.5%), and 73 had cystic periventricular leukomalacia (1.7%). Outcomes were available for 3008 of 3345 neonates with ventriculomegaly or normal scans (90%). Compared with normal cranial ultrasonograms, ventriculomegaly was associated with lower gestational age, male sex, and bronchopulmonary dysplasia, late-onset sepsis, meningitis, necrotizing enterocolitis, and stage 3 retinopathy of prematurity. After adjustment, neonates with ventriculomegaly had higher odds of neurodevelopmental impairment (odds ratio [OR], 3.07; 95% CI, 2.13-4.43), cognitive impairment (OR, 3.23; 95% CI, 2.09-4.99), moderate/severe cerebral palsy (OR, 3.68; 95% CI, 2.08-6.51), death/neurodevelopmental impairment (OR, 2.17; 95% CI, 1.62-2.91), but not death alone (OR, 1.09; 95% CI, 0.76-1.57). Behavioral outcomes did not differ. Conclusions and Relevance Nonhemorrhagic ventriculomegaly is associated with increased odds of neurodevelopmental impairment among extremely preterm neonates.
- Published
- 2017
206. A Noninvasive Molecular Clock for Fetal Development Predicts Gestational Age and Preterm Delivery
- Author
-
Thuy T. M. Ngo, Mira N. Moufarrej, Marie-Louise H. Rasmussen, Joan Camunas-Soler, Wenying Pan, Jennifer Okamoto, Norma F. Neff, Keli Liu, Ronald J. Wong, Katheryne Downes, Robert Tibshirani, Gary M. Shaw, Line Skotte, David K. Stevenson, Joseph R. Biggio, Michal A. Elovitz, Mads Melbye, and Stephen R. Quake
- Subjects
Fetus ,medicine.medical_specialty ,business.industry ,Obstetrics ,Medicine ,Gestational age ,Molecular clock ,business ,Preterm delivery - Abstract
We performed a high time-resolution, longitudinal study of normal pregnancy development by measuring cell-free RNA (cfRNA) in blood from women during each week of pregnancy. Analysis of tissue-specific transcripts in these samples enabled us to follow fetal and placental development with high resolution and sensitivity, and also to detect gene-specific responses of the maternal immune system to pregnancy. We established a “clock” for normal pregnancy development and enabled a direct molecular approach to determine expected delivery dates with comparable accuracy to ultrasound, creating the basis for a portable, inexpensive fetal dating method. We also identified a related gene set that accurately discriminated women at risk for spontaneous preterm delivery up to two months in advance of labor, forming the basis of a potential screening test for risk of preterm delivery.
- Published
- 2017
207. Bilirubin binding in jaundiced newborns: from bench to bedside?
- Author
-
David K. Stevenson, Ronald J. Wong, Charles E. Ahlfors, and Vinod K. Bhutani
- Subjects
medicine.medical_specialty ,Bilirubin ,medicine.medical_treatment ,Population ,Exchange transfusion ,Gastroenterology ,Risk Assessment ,Infant, Newborn, Diseases ,Bilirubin binding ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Neonatal Screening ,030225 pediatrics ,Internal medicine ,Albumins ,Medicine ,Humans ,Mass Screening ,In patient ,Fluorometry ,education ,education.field_of_study ,Binding Sites ,business.industry ,Infant, Newborn ,Jaundice ,Models, Theoretical ,Phototherapy ,Bench to bedside ,Jaundice, Neonatal ,Kinetics ,Increased risk ,chemistry ,Pediatrics, Perinatology and Child Health ,medicine.symptom ,business ,030217 neurology & neurosurgery ,Protein Binding - Abstract
Background: Bilirubin-induced neurologic dysfunction (BIND) is a spectrum of preventable neurological sequelae in jaundiced newborns. Current total plasma bilirubin (BT) concentration thresholds for phototherapy and/or exchange transfusion poorly predict BIND. Methods: The unbound (free) bilirubin (Bf) measured at these BT thresholds provides additional information about the risk for BIND. Bf can be readily adapted to clinical use by determining Bf population parameters at current BT thresholds. These parameters can be established using a plasma bilirubin binding panel (BBP) consisting of BT, Bf, and two empiric constants, the maximum BT (BTmax) and the corresponding equilibrium association bilirubin constant (K). Results: BTmax and K provide the variables needed to accurately estimate Bf at BT
- Published
- 2017
208. Exome Sequencing of Neonatal Blood Spots and the Identification of Genes Implicated in Bronchopulmonary Dysplasia
- Author
-
Laura L. Jeliffe-Pawlowski, Kun-Hsing Yu, David K. Stevenson, Michael Snyder, Gary M. Shaw, Hugh O'Brodovich, Jingjing Li, Jeffrey B. Gould, and John Oehlert
- Subjects
Male ,Pulmonary and Respiratory Medicine ,Nonsynonymous substitution ,Haploinsufficiency ,Disease ,Biology ,Critical Care and Intensive Care Medicine ,Bioinformatics ,Mice ,Negative selection ,Neonatal Screening ,Morphogenesis ,Twins, Dizygotic ,medicine ,Animals ,Humans ,Exome ,Genetic Predisposition to Disease ,Lung ,Wnt Signaling Pathway ,Gene ,Exome sequencing ,Bronchopulmonary Dysplasia ,Genetic association ,Genetics ,Blood Specimen Collection ,Mortality rate ,Infant, Newborn ,Infant ,Sequence Analysis, DNA ,Twins, Monozygotic ,medicine.disease ,Bronchopulmonary dysplasia ,Case-Control Studies ,Infant, Extremely Premature ,Female ,Original Article ,Infant, Premature ,Genome-Wide Association Study - Abstract
Bronchopulmonary dysplasia (BPD), a prevalent severe lung disease of premature infants, has a strong genetic component. Large-scale genome-wide association studies for common variants have not revealed its genetic basis.Given the historical high mortality rate of extremely preterm infants who now survive and develop BPD, we hypothesized that risk loci underlying this disease are under severe purifying selection during evolution; thus, rare variants likely explain greater risk of the disease.We performed exome sequencing on 50 BPD-affected and unaffected twin pairs using DNA isolated from neonatal blood spots and identified genes affected by extremely rare nonsynonymous mutations. Functional genomic approaches were then used to systematically compare these affected genes.We identified 258 genes with rare nonsynonymous mutations in patients with BPD. These genes were highly enriched for processes involved in pulmonary structure and function including collagen fibril organization, morphogenesis of embryonic epithelium, and regulation of Wnt signaling pathway; displayed significantly elevated expression in fetal and adult lungs; and were substantially up-regulated in a murine model of BPD. Analyses of mouse mutants revealed their phenotypic enrichment for embryonic development and the cyanosis phenotype, a clinical manifestation of BPD.Our study supports the role of rare variants in BPD, in contrast with the role of common variants targeted by genome-wide association studies. Overall, our study is the first to sequence BPD exomes from newborn blood spot samples and identify with high confidence genes implicated in BPD, thereby providing important insights into its biology and molecular etiology.
- Published
- 2015
209. Neonatal brain microstructure correlates of neurodevelopment and gait in preterm children 18–22 mo of age: an MRI and DTI study
- Author
-
Ximena Stecher, Jessica Rose, Katelyn Cahill-Rowley, David K. Stevenson, Kristen W. Yeom, Susan R. Hintz, Naama Barnea-Goraly, and Rachel Vassar
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Pathology ,Gestational Age ,Motor Activity ,behavioral disciplines and activities ,White matter ,Child Development ,Cognition ,Predictive Value of Tests ,Risk Factors ,Cerebellum ,medicine ,Neonatal brain ,Humans ,Infant, Very Low Birth Weight ,Motor activity ,Gait ,Neurologic Examination ,medicine.diagnostic_test ,Extramural ,business.industry ,Age Factors ,Infant, Newborn ,Infant ,Gestational age ,Magnetic resonance imaging ,Prognosis ,Magnetic Resonance Imaging ,White Matter ,Diffusion Tensor Imaging ,medicine.anatomical_structure ,nervous system ,Infant Behavior ,Multivariate Analysis ,Pediatrics, Perinatology and Child Health ,Linear Models ,Female ,business ,human activities ,Infant, Premature ,Diffusion MRI - Abstract
Near-term brain structure was examined in preterm infants in relation to neurodevelopment. We hypothesized that near-term macrostructural brain abnormalities identified using conventional magnetic resonance imaging (MRI), and white matter (WM) microstructure detected using diffusion tensor imaging (DTI), would correlate with lower cognitive and motor development and slower, less-stable gait at 18-22 mo of age.One hundred and two very-low-birth-weight preterm infants (≤1,500 g birth weight; ≤32 wk gestational age) were recruited prior to routine near-term brain MRI at 36.6 ± 1.8 wk postmenstrual age. Cerebellar and WM macrostructure was assessed on conventional structural MRI. DTI was obtained in 66 out of 102 and WM microstructure was assessed using fractional anisotropy and mean diffusivity (MD) in six subcortical brain regions defined by DiffeoMap neonatal atlas. Neurodevelopment was assessed with Bayley-Scales-of-Infant-Toddler-Development, 3rd-Edition (BSID-III); gait was assessed using an instrumented mat.Neonates with cerebellar abnormalities identified using MRI demonstrated lower mean BSID-III cognitive composite scores (89.0 ± 10.1 vs. 97.8 ± 12.4; P = 0.002) at 18-22 mo. Neonates with higher DTI-derived left posterior limb of internal capsule (PLIC) MD demonstrated lower cognitive and motor composite scores (r = -0.368; P = 0.004; r = -0.354; P = 0.006) at 18-22 mo; neonates with higher genu MD demonstrated slower gait velocity (r = -0.374; P = 0.007). Multivariate linear regression significantly predicted cognitive (adjusted r(2) = 0.247; P = 0.002) and motor score (adjusted r(2) = 0.131; P = 0.017).Near-term cerebellar macrostructure and PLIC and genu microstructure were predictive of early neurodevelopment and gait.
- Published
- 2015
210. Neonatal Biomarkers of Inflammation: Correlates of Early Neurodevelopment and Gait in Very-Low-Birth-Weight Preterm Children
- Author
-
Katelyn Cahill-Rowley, Susan R. Hintz, Rachel Vassar, David K. Stevenson, and Jessica Rose
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Neonatal intensive care unit ,Gestational Age ,Motor Activity ,Bayley Scales of Infant Development ,Sepsis ,Child Development ,Cognition ,Enterocolitis, Necrotizing ,Risk Factors ,Intensive Care Units, Neonatal ,medicine ,Birth Weight ,Humans ,Infant, Very Low Birth Weight ,Speech ,Gait ,Bronchopulmonary Dysplasia ,Inflammation ,Psychiatric Status Rating Scales ,business.industry ,Infant, Newborn ,Infant ,Obstetrics and Gynecology ,Gestational age ,Retinopathy of prematurity ,medicine.disease ,Low birth weight ,C-Reactive Protein ,Bronchopulmonary dysplasia ,Multivariate Analysis ,Pediatrics, Perinatology and Child Health ,Necrotizing enterocolitis ,Linear Models ,Female ,medicine.symptom ,business ,Biomarkers ,Infant, Premature - Abstract
Neonatal biomarkers of inflammation were examined in relation to early neurodevelopment and gait in very-low-birth-weight (VLBW) preterm children. We hypothesized that preterm infants exposed to higher levels of neonatal inflammation would demonstrate lower scores on Bayley Scales of Infant Toddler Development, 3rd ed. (BSID-III) and slower gait velocity at 18 to 22 months adjusted age.A total of 102 VLBW preterm infants (birthweight [BW] ≤ 1,500 g, gestational age [GA] ≤ 32 weeks) admitted to neonatal intensive care unit [NICU] were recruited. Neonatal risk factors examined were GA at birth, BW, bronchopulmonary dysplasia, necrotizing enterocolitis, retinopathy of prematurity, sepsis, and serum C-reactive protein (CRP), albumin, and total bilirubin over first 2 postnatal weeks. At 18 to 22 months, neurodevelopment was assessed with BSID-III and gait was assessed with an instrumented mat.Children with neonatal CRP ≥ 0.20 mg/dL (n = 52) versus0.20 mg/dL (n = 37) had significantly lower BSID-III composite cognitive (92.0 ± 13.1 vs. 100.1 ± 9.6, p = 0.002), language (83.9 ± 16.0 vs. 95.8 ± 14.2, p 0.001), and motor scores (90.0 ± 13.2 vs. 98.8 ± 10.1, p = 0.002), and slower gait velocity (84.9 ± 19.0 vs. 98.0 ± 22.4 cm/s, p = 0.004). Higher neonatal CRP correlated with lower cognitive (rho = - 0.327, p = 0.002), language (rho = - 0.285, p = 0.007), and motor scores (rho = - 0.257, p = 0.015), and slower gait (rho = - 0.298, p = 0.008). Multivariate analysis demonstrated neonatal CRP ≥ 0.20 mg/dL significantly predicted BSID-III cognitive (adjusted R(2) = 0.104, p = 0.008), language (adjusted R(2) = 0.124, p = 0.001), and motor scores (adjusted R(2) = 0.122, p = 0.004).Associations between low-level neonatal inflammation and neurodevelopment suggest early biomarkers that may inform neuroprotective treatment for preterm children.
- Published
- 2015
211. Implementing Mass Cytometry at the Bedside to Study the Immunological Basis of Human Diseases: Distinctive Immune Features in Patients with a History of Term or Preterm Birth
- Author
-
Quentin Baca, David K. Stevenson, Martin S. Angst, Gary M. Shaw, Martha Tingle, Nima Aghaeepour, Edward A. Ganio, Yasser Y. El-Sayed, Brice Gaudilliere, Garry P. Nolan, Gabriela K. Fragiadakis, Cele Quaintance, David B. Lewis, Ronald J. Wong, and Hope L. Lancero
- Subjects
Pregnancy ,Histology ,medicine.diagnostic_test ,biology ,business.industry ,Cell Biology ,medicine.disease ,Peripheral blood mononuclear cell ,Pathology and Forensic Medicine ,Flow cytometry ,Immune system ,Immunology ,medicine ,biology.protein ,Mass cytometry ,Antibody ,business ,Cytometry ,Whole blood - Abstract
Single-cell technologies have immense potential to shed light on molecular and biological processes that drive human diseases. Mass cytometry (or Cytometry by Time Of Flight mass spectrometry, CyTOF) has already been employed in clinical studies to comprehensively survey patients' circulating immune system. As interest in the "bedside" application of mass cytometry is growing, the delineation of relevant methodological issues is called for. This report uses a newly generated dataset to discuss important methodological considerations when mass cytometry is implemented in a clinical study. Specifically, the use of whole blood samples versus peripheral blood mononuclear cells (PBMCs), design of mass-tagged antibody panels, technical and analytical implications of sample barcoding, and application of traditional and unsupervised approaches to analyze high-dimensional mass cytometry datasets are discussed. A mass cytometry assay was implemented in a cross-sectional study of 19 women with a history of term or preterm birth to determine whether immune traits in peripheral blood differentiate the two groups in the absence of pregnancy. Twenty-seven phenotypic and 11 intracellular markers were simultaneously analyzed in whole blood samples stimulated with lipopolysaccharide (LPS at 0, 0.1, 1, 10, and 100 ng mL(-1)) to examine dose-dependent signaling responses within the toll-like receptor 4 (TLR4) pathway. Complementary analyses, grounded in traditional or unsupervised gating strategies of immune cell subsets, indicated that the prpS6 and pMAPKAPK2 responses in classical monocytes are accentuated in women with a history of preterm birth (FDR
- Published
- 2015
212. Heme oxygenase-1 promoter polymorphisms and risk of spina bifida
- Author
-
Hui Zhao, Matthew B. Wallenstein, David K. Stevenson, Ronald J. Wong, Kazumichi Fujioka, Gary M. Shaw, and Wei Yang
- Subjects
Genetics ,congenital, hereditary, and neonatal diseases and abnormalities ,Embryology ,Linkage disequilibrium ,Spina bifida ,Haplotype ,General Medicine ,Biology ,medicine.disease ,Monitoring program ,Pediatrics, Perinatology and Child Health ,Genotype ,medicine ,SNP ,Restriction fragment length polymorphism ,Allele frequency ,Developmental Biology - Abstract
Background Spina bifida is the most common form of neural tube defects (NTDs). Etiologies of NTDs are multifactorial, and oxidative stress is believed to play a key role in NTD development. Heme oxygenase (HO), the rate-limiting enzyme in heme degradation, has multiple protective properties including mediating antioxidant processes, making it an ideal candidate for study. The inducible HO isoform (HO-1) has two functional genetic polymorphisms: (GT)n dinucleotide repeats and A(-413)T SNP (rs2071746), both of which can affect its promoter activity. However, no study has investigated a possible association between HO-1 genetic polymorphisms and risk of NTDs. Methods: This case-control study included 152 spina bifida cases (all myelomeningoceles) and 148 nonmalformed controls obtained from the California Birth Defects Monitoring Program reflecting births during 1990 to 1999. Genetic polymorphisms were determined by polymerase chain reaction and amplified fragment length polymorphisms/restriction fragment length polymorphisms using genomic DNA extracted from archived newborn blood spots. Genotype and haplotype frequencies of two HO-1 promoter polymorphisms between cases and controls were compared. Results: For (GT)n dinucleotide repeat lengths and the A(-413)T SNP, no significant differences in allele frequencies or genotypes were found. Linkage disequilibrium was observed between the HO-1 polymorphisms (D′: 0.833); however, haplotype analyses did not show increased risk of spina bifida overall or by race/ethnicity. Conclusion: Although, an association was not found between HO-1 polymorphisms and risk of spina bifida, we speculate that the combined effect of low HO-1 expression and exposures to known environmental oxidative stressors (low folate status or diabetes), may overwhelm antioxidant defenses and increase risk of NTDs and warrants further study. Birth Defects Research (Part A), 2014. © 2014 Wiley Periodicals, Inc.
- Published
- 2015
213. Association ofHMOX1gene promoter polymorphisms with hyperbilirubinemia in the early neonatal period
- Author
-
Tomoyuki Yokota, Kazumoto Iijima, Hajime Nakamura, Ichiro Morioka, Mariko Taniguchi-Ikeda, Yoshinori Katayama, Hui Zhao, Ronald J. Wong, and David K. Stevenson
- Subjects
education.field_of_study ,HMOX1 ,Bilirubin ,Population ,Promoter ,Biology ,Molecular biology ,Genotype frequency ,Heme oxygenase ,chemistry.chemical_compound ,chemistry ,Pediatrics, Perinatology and Child Health ,Gene expression ,Allele ,education - Abstract
Background Heme oxygenase (HO) is the rate-limiting enzyme in the heme degradation pathway that produces bilirubin. The promoter region of human heme oxygenase-1 (HMOX1) contains a polymorphic (GT)n repeat that can regulate gene expression. Here, we investigated the association of (GT)n repeat length in the HMOX1 promoter region with neonatal hyperbilirubinemia in a population of Japanese term neonates. Methods Using polymerase chain reaction and fragment analysis, we determined the number of (GT)n repeats in 149 Japanese neonates. To omit the effects of the G71R mutation in uridine diphosphoglucuronosyltransferase on hyperbilirubinemia, we excluded 41 neonates with the G71R mutation. As a result, 25 neonates with hyperbilirubinemia and 83 non-hyperbilirubinemic controls were included in this prospective case–control study. Allele and genotype frequencies of (GT)n repeats in the HMOX1 gene were compared between hyperbilirubinemic and non-hyperbilirubinemic control neonates. Results The prevalence of short alleles (
- Published
- 2015
214. Unique Roles of Infiltrating Myeloid Cells in the Murine Uterus during Early to Midpregnancy
- Author
-
David K. Stevenson, Ronald J. Wong, Hui Zhao, Stephanie Schulz, Yang Yang, and Flora Kalish
- Subjects
Myeloid ,Neutrophils ,CD14 ,Interleukin-1beta ,Immunology ,Lipopolysaccharide Receptors ,Uterus ,Inflammation ,Proinflammatory cytokine ,Mice ,Immune system ,Downregulation and upregulation ,Cell Movement ,Pregnancy ,medicine ,Animals ,Immunology and Allergy ,Myeloid Cells ,Fetal Death ,Cell Proliferation ,Mice, Inbred BALB C ,Tumor Necrosis Factor-alpha ,business.industry ,medicine.disease ,Killer Cells, Natural ,medicine.anatomical_structure ,Neutrophil Infiltration ,Female ,Uterine Hemorrhage ,medicine.symptom ,business ,Infiltration (medical) - Abstract
Leukocyte infiltration into the uterus is a characteristic feature in early to midpregnancy, but the composition and function of these leukocytes are not well understood. Using a pregnant murine model, we showed that myeloid cells and uterine NK (uNK) cells were the predominant populations in uteri during early to midgestation, whereas T and B cells were constrained. Uterine myeloid populations included cells that infiltrated from the circulation (myeloid-derived suppressor cells [MDSCs], monocyte-derived macrophages [Mφs], and dendritic cells [DCs]) or proliferated from resident precursors (resident Mφs [Re-Mφs] and DCs). CD11bhiLy6-Ghi cells, representing neutrophils in both blood and uterine MDSCs, significantly increased from embryonic days 8.5 to 9.5. To understand their putative functions, we used anti–Gr-1 Ab to deplete circulating neutrophils and uterine MDSCs. In the absence of MDSC suppression, uterine DCs, T cells, and regulatory T cells expanded. Conversely, uterine MDSCs responded to LPS-induced inflammation and transformed into CD14+-activated neutrophils, resulting in an upregulation of tolerogenic DCs. A high dose of LPS (2.5 μg/mouse) significantly increased the influx of neutrophils and production of proinflammatory cytokines, such as IL-1β and TNF-α, resulting in the reduction of Re-Mφs and uNK cells, and led to placental hemorrhages and fetal deaths. In summary, uterine MDSCs are important in early to midpregnancy by responding to the maternal immunologic milieu and protecting uNK cells and Re-Mφs via MDSC’s suppressive and anti-inflammatory functions. Upsetting this delicate immune balance by factors leading to either insufficient MDSCs or excessive neutrophil infiltration in the fetomaternal interface may contribute to pregnancy failure.
- Published
- 2015
215. Determinants of chronic lung disease severity in the first year of life; A population based study
- Author
-
Susan Gage, Jeffrey B. Gould, John Oehlert, Gary M. Shaw, David K. Stevenson, Peiyi Kan, and Hugh O'Brodovich
- Subjects
Pulmonary and Respiratory Medicine ,education.field_of_study ,Pediatrics ,medicine.medical_specialty ,Neonatal intensive care unit ,business.industry ,Population ,Gestational age ,Retinopathy of prematurity ,medicine.disease ,Bronchopulmonary dysplasia ,Lung disease ,Pediatrics, Perinatology and Child Health ,medicine ,Stage (cooking) ,business ,education ,Pulmonologists - Abstract
Summary Objectives First, create a clinical severity score for patients with chronic lung disease of infancy (CLDi) following neonatal intensive care unit (NICU) stay. Second, using California wide population-based data, identify factors associated with clinical severity of CLDi at 4–9 months corrected gestational age (CGA). Study Design Pediatric pulmonologists ranked and weighted eight factors reflecting clinical severity of CLDi. Utilizing these data we scored and assigned these to 4–9 month old CGA moderate/severe bronchopulmonary dysplasia (BPD) infants, born
- Published
- 2015
216. Neuroimaging and Neurodevelopmental Outcome in Extremely Preterm Infants
- Author
-
Susan R, Hintz, Patrick D, Barnes, Dorothy, Bulas, Thomas L, Slovis, Neil N, Finer, Lisa A, Wrage, Abhik, Das, Jon E, Tyson, David K, Stevenson, Waldemar A, Carlo, Michele C, Walsh, Abbot R, Laptook, Bradley A, Yoder, Krisa P, Van Meurs, Roger G, Faix, Wade, Rich, Nancy S, Newman, Helen, Cheng, Roy J, Heyne, Betty R, Vohr, Michael J, Acarregui, Yvonne E, Vaucher, Athina, Pappas, Myriam, Peralta-Carcelen, Deanne E, Wilson-Costello, Patricia W, Evans, Ricki F, Goldstein, Gary J, Myers, Brenda B, Poindexter, Elisabeth C, McGowan, Ira, Adams-Chapman, Janell, Fuller, Rosemary D, Higgins, and Mary, Johnson
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Developmental Disabilities ,Visual impairment ,Neuroimaging ,medicine ,Humans ,Prospective Studies ,Prospective cohort study ,medicine.diagnostic_test ,business.industry ,Infant, Newborn ,Brain ,Infant ,Magnetic resonance imaging ,Odds ratio ,Echoencephalography ,Magnetic Resonance Imaging ,Confidence interval ,Infant, Extremely Premature ,Pediatrics, Perinatology and Child Health ,Gestation ,Female ,medicine.symptom ,business - Abstract
BACKGROUND: Extremely preterm infants are at risk for neurodevelopmental impairment (NDI). Early cranial ultrasound (CUS) is usual practice, but near-term brain MRI has been reported to better predict outcomes. We prospectively evaluated MRI white matter abnormality (WMA) and cerebellar lesions, and serial CUS adverse findings as predictors of outcomes at 18 to 22 months’ corrected age. METHODS: Early and late CUS, and brain MRI were read by masked central readers, in a large cohort (n = 480) of infants RESULTS: Of 480 infants, 15 died and 20 were lost. Increasing severity of WMA and significant cerebellar lesions on MRI were associated with adverse outcomes. Cerebellar lesions were rarely identified by CUS. In full multivariable models, both late CUS and MRI, but not early CUS, remained independently associated with NDI or death (MRI cerebellar lesions: odds ratio, 3.0 [95% confidence interval: 1.3–6.8]; late CUS: odds ratio, 9.8 [95% confidence interval: 2.8–35]), and significant gross motor impairment or death. In models that did not include late CUS, MRI moderate-severe WMA was independently associated with adverse outcomes. CONCLUSIONS: Both late CUS and near-term MRI abnormalities were associated with outcomes, independent of early CUS and other factors, underscoring the relative prognostic value of near-term neuroimaging.
- Published
- 2015
217. Neonatal bilirubin binding capacity discerns risk of neurological dysfunction
- Author
-
Lizhong Du, Lihua Chen, Ronald J. Wong, Zheng Shen, Vinod K. Bhutani, David K. Stevenson, Angelo A. Lamola, and Martin E. Castillo Cuadrado
- Subjects
medicine.medical_specialty ,Bilirubin ,medicine.medical_treatment ,Exchange transfusion ,Gestational Age ,Logistic regression ,Risk Assessment ,Gastroenterology ,chemistry.chemical_compound ,Internal medicine ,medicine ,Humans ,Fluorometry ,Prospective Studies ,Prospective cohort study ,Whole blood ,Analysis of Variance ,business.industry ,Infant, Newborn ,Albumin ,Gestational age ,Logistic Models ,chemistry ,Pediatrics, Perinatology and Child Health ,Neurotoxicity Syndromes ,Analysis of variance ,business ,Infant, Premature ,Protein Binding - Abstract
Bilirubin binding capacity (BBC) defines the dynamic relationship between an infant’s level of unbound or “free” bilirubin and his/her ability to “tolerate” increasing bilirubin loads. BBC is not synonymous with albumin (Alb) levels because Alb binding of bilirubin is confounded by a variety of molecular, biologic, and metabolic factors. We utilized a novel modification of a previously developed hematofluorometric method to directly assay BBC in whole blood from preterm and term neonates and then combined these data with an archived database. Total bilirubin (TB) was also measured, and multiple regression modeling was used to determine whether BBC in combination with TB measurements can assess an infant’s risk for developing bilirubin-induced neurotoxicity. TB and BBC levels ranged from 0.7–22.8 to 6.3–47.5 mg/dl, respectively. Gestational age (GA) correlated with BBC (r = 0.54; P < 0.0002) with a slope of 0.93 mg/dl/wk by logistic regression. Our calculations demonstrate that recently recommended GA-modulated TB thresholds for phototherapy and exchange transfusion correspond to 45 and 67% saturation of our observed regression line, respectively. We speculate that the spread of BBC levels around the regression line (±5.8 mg/dl) suggests that individualized BBC assays would provide a robust approach to gauge risk of bilirubin neurotoxicity compared with TB and GA.
- Published
- 2014
218. Direct Antiglobulin Titer Strength and Hyperbilirubinemia
- Author
-
Ronald J. Wong, Michael Kaplan, David K. Stevenson, Hendrik J. Vreman, and Cathy Hammerman
- Subjects
Male ,medicine.medical_specialty ,Bilirubin ,Gastroenterology ,Agglutination technique ,Cohort Studies ,chemistry.chemical_compound ,Internal medicine ,mental disorders ,parasitic diseases ,medicine ,Humans ,Hyperbilirubinemia ,business.industry ,Infant, Newborn ,food and beverages ,Increased hemolysis ,medicine.disease ,Confidence interval ,Total hemoglobin ,Hemolysis ,Surgery ,Coombs Test ,Titer ,nervous system ,chemistry ,Pediatrics, Perinatology and Child Health ,Carboxyhemoglobin ,Blood Group Antigens ,Female ,business - Abstract
BACKGROUND AND OBJECTIVES: We recently demonstrated that direct antiglobulin titer (DAT) positive, blood group A or B newborns born to group O mothers had a high incidence of hyperbilirubinemia, attributable to increased hemolysis. We reanalyzed our data asking whether increasing DAT strength plays a modulating role in the pathophysiology of the hemolysis and hyperbilirubinemia. METHODS: Data from previously published DAT-positive, ABO-heterospecific neonates were analyzed for hyperbilirubinemia and hemolysis according to strength of DAT. DAT was measured by using a gel agglutination technique and reported as values ranging from DAT ± to DAT ++++. Hemolysis was evaluated by blood carboxyhemoglobin corrected for inspired, ambient CO (COHbc), and expressed as percent total hemoglobin (tHb). Hyperbilirubinemia was defined as any plasma total bilirubin value >95th percentile on the hour-specific nomogram. RESULTS: Hyperbilirubinemia was more prevalent in those with DAT ++ readings (16 of 20, 80%) than those both DAT ± (37 of 87 [42.5%], relative risk: 1.88, 95% confidence interval: 1.35–2.61) and DAT + (32 of 56 [57.1%], relative risk: 1.40, 95% confidence interval: 1.02–1.92). COHbc values were higher for those with DAT ++ (1.45 ± 0.49% tHb [mean ± SD]) than those DAT ± (1.20 ± 0.37% tHb, P = .01) or DAT + (1.22 ± 0.37% tHb, P = .02). CONCLUSIONS: DAT ++ readings were associated with a higher incidence of hyperbilirubinemia and higher COHbc values than DAT ± or DAT + counterparts. Increasing DAT strength may be a modulator of hemolysis and hyperbilirubinemia in ABO-heterospecific neonates. DAT strength, and not merely DAT presence or absence, should be taken into consideration in the management of ABO-heterospecific newborns.
- Published
- 2014
219. Prediction of cognitive and motor development in preterm children using exhaustive feature selection and cross-validation of near-term white matter microstructure
- Author
-
Katelyn Cahill-Rowley, Jessica Rose, David K. Stevenson, Kristen W. Yeom, Kornél Schadl, and Rachel Vassar
- Subjects
Motor development ,BSID ,Neurodevelopment ,Audiology ,Logistic regression ,Bayley Scales of Infant Development ,lcsh:RC346-429 ,Developmental psychology ,0302 clinical medicine ,Neonate ,Gyrus ,Risk Factors ,Medicine ,Infant, Very Low Birth Weight ,Diagnosis, Computer-Assisted ,Motor skill ,Movement Disorders ,Brain ,Cognition ,Regular Article ,Magnetic Resonance Imaging ,White Matter ,medicine.anatomical_structure ,Diffusion tensor imaging ,Neurology ,DTI ,lcsh:R858-859.7 ,Infant, Premature ,MRI ,medicine.medical_specialty ,Cognitive Neuroscience ,Neuroimaging ,lcsh:Computer applications to medicine. Medical informatics ,Sensitivity and Specificity ,White matter ,03 medical and health sciences ,Preterm ,030225 pediatrics ,Machine learning ,Humans ,Radiology, Nuclear Medicine and imaging ,Cognitive Dysfunction ,lcsh:Neurology. Diseases of the nervous system ,business.industry ,Very-low-birth-weight ,Infant, Newborn ,Infant ,VLBW ,Cognitive development ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,Diffusion MRI - Abstract
Background: Advanced neuroimaging and computational methods offer opportunities for more accurate prognosis. We hypothesized that near-term regional white matter (WM) microstructure, assessed on diffusion tensor imaging (DTI), using exhaustive feature selection with cross-validation would predict neurodevelopment in preterm children. Methods: Near-term MRI and DTI obtained at 36.6±1.8weeks postmenstrual age in 66 very-low-birth-weight preterm neonates were assessed. 60/66 had follow-up neurodevelopmental evaluation with Bayley Scales of Infant-Toddler Development, 3rd-edition (BSID-III) at 18–22months. Linear models with exhaustive feature selection and leave-one-out cross-validation computed based on DTI identified sets of three brain regions most predictive of cognitive and motor function; logistic regression models were computed to classify high-risk infants scoring one standard deviation below mean. Results: Cognitive impairment was predicted (100% sensitivity, 100% specificity; AUC=1) by near-term right middle-temporal gyrus MD, right cingulate-cingulum MD, left caudate MD. Motor impairment was predicted (90% sensitivity, 86% specificity; AUC=0.912) by left precuneus FA, right superior occipital gyrus MD, right hippocampus FA. Cognitive score variance was explained (29.6%, cross-validated Rˆ2=0.296) by left posterior-limb-of-internal-capsule MD, Genu RD, right fusiform gyrus AD. Motor score variance was explained (31.7%, cross-validated Rˆ2=0.317) by left posterior-limb-of-internal-capsule MD, right parahippocampal gyrus AD, right middle-temporal gyrus AD. Conclusion: Search in large DTI feature space more accurately identified neonatal neuroimaging correlates of neurodevelopment. Keywords: MRI, DTI, Diffusion tensor imaging, Neonate, Preterm, Very-low-birth-weight, VLBW, Machine learning, Neurodevelopment, BSID, Cognitive development, Motor development
- Published
- 2017
220. A proteomic clock of human pregnancy
- Author
-
Brice Gaudilliere, Anthony Culos, Virginia D. Winn, Yasser Y. El-Sayed, Maurice L. Druzin, Martin S. Angst, Ronald S. Gibbs, Robert Tibshirani, David K. Stevenson, Gary M. Shaw, Nima Aghaeepour, Benoit Lehallier, Quentin Baca, Edward A. Ganio, Mohammad Sajjad Ghaemi, Ronald J. Wong, and Yair J. Blumenfeld
- Subjects
0301 basic medicine ,Adult ,CD4-Positive T-Lymphocytes ,Proteome ,Gestational Age ,Computational biology ,Somatomammotropin ,03 medical and health sciences ,0302 clinical medicine ,Glypicans ,Predictive Value of Tests ,Pregnancy ,medicine ,STAT5 Transcription Factor ,Humans ,Placental lactogen ,Granulins ,Janus Kinases ,Fetus ,030219 obstetrics & reproductive medicine ,business.industry ,Postpartum Period ,Obstetrics and Gynecology ,Gestational age ,Models, Theoretical ,medicine.disease ,Placental Lactogen ,Blood proteins ,STAT Transcription Factors ,030104 developmental biology ,Gene Ontology ,Female ,Pregnancy Trimesters ,business ,Postpartum period ,Algorithms ,Biomarkers ,Signal Transduction - Abstract
Background Early detection of maladaptive processes underlying pregnancy-related pathologies is desirable because it will enable targeted interventions ahead of clinical manifestations. The quantitative analysis of plasma proteins features prominently among molecular approaches used to detect deviations from normal pregnancy. However, derivation of proteomic signatures sufficiently predictive of pregnancy-related outcomes has been challenging. An important obstacle hindering such efforts were limitations in assay technology, which prevented the broad examination of the plasma proteome. Objective The recent availability of a highly multiplexed platform affording the simultaneous measurement of 1310 plasma proteins opens the door for a more explorative approach. The major aim of this study was to examine whether analysis of plasma collected during gestation of term pregnancy would allow identifying a set of proteins that tightly track gestational age. Establishing precisely timed plasma proteomic changes during term pregnancy is a critical step in identifying deviations from regular patterns caused by fetal and maternal maladaptations. A second aim was to gain insight into functional attributes of identified proteins and link such attributes to relevant immunological changes. Study Design Pregnant women participated in this longitudinal study. In 2 subsequent sets of 21 (training cohort) and 10 (validation cohort) women, specific blood specimens were collected during the first (7–14 weeks), second (15–20 weeks), and third (24–32 weeks) trimesters and 6 weeks postpartum for analysis with a highly multiplexed aptamer-based platform. An elastic net algorithm was applied to infer a proteomic model predicting gestational age. A bootstrapping procedure and piecewise regression analysis was used to extract the minimum number of proteins required for predicting gestational age without compromising predictive power. Gene ontology analysis was applied to infer enrichment of molecular functions among proteins included in the proteomic model. Changes in abundance of proteins with such functions were linked to immune features predictive of gestational age at the time of sampling in pregnancies delivering at term. Results An independently validated model consisting of 74 proteins strongly predicted gestational age (P = 3.8 × 10–14, R = 0.97). The model could be reduced to 8 proteins without losing its predictive power (P = 1.7 × 10–3, R = 0.91). The 3 top ranked proteins were glypican 3, chorionic somatomammotropin hormone, and granulins. Proteins activating the Janus kinase and signal transducer and activator of transcription pathway were enriched in the proteomic model, chorionic somatomammotropin hormone being the top-ranked protein. Abundance of chorionic somatomammotropin hormone strongly correlated with signal transducer and activator of transcription-5 signaling activity in CD4 T cells, the endogenous cell-signaling event most predictive of gestational age. Conclusion Results indicate that precisely timed changes in the plasma proteome during term pregnancy mirror a proteomic clock. Importantly, the combined use of several plasma proteins was required for accurate prediction. The exciting promise of such a clock is that deviations from its regular chronological profile may assist in the early diagnoses of pregnancy-related pathologies, and point to underlying pathophysiology. Functional analysis of the proteomic model generated the novel hypothesis that chrionic somatomammotropin hormone may critically regulate T-cell function during pregnancy.
- Published
- 2017
221. Replication and refinement of a vaginal microbial signature of preterm birth in two racially distinct cohorts of US women
- Author
-
Maurice L. Druzin, David K. Stevenson, Benjamin J. Callahan, Daniel B. DiGiulio, Elizabeth K. Costello, Gary M. Shaw, Christine L. Sun, David A. Relman, Ronald J. Wong, Pratheepa Jeganathan, Daniela S. Aliaga Goltsman, Joseph R. Biggio, and Susan Holmes
- Subjects
0301 basic medicine ,Adult ,DNA Replication ,030106 microbiology ,Physiology ,macromolecular substances ,Biology ,Bioinformatics ,medicine.disease_cause ,environment and public health ,White People ,Cohort Studies ,03 medical and health sciences ,Gardnerella ,Pregnancy ,Lactobacillus ,RNA, Ribosomal, 16S ,medicine ,Lactobacillus iners ,Gardnerella vaginalis ,Humans ,Microbiome ,Multidisciplinary ,Lactobacillus crispatus ,integumentary system ,Microbiota ,Biological Sciences ,biology.organism_classification ,medicine.disease ,United States ,Black or African American ,030104 developmental biology ,Case-Control Studies ,Cohort ,Vagina ,Premature Birth ,Female - Abstract
Preterm birth (PTB) is the leading cause of neonatal morbidity and mortality. Previous studies have suggested that the maternal vaginal microbiota contributes to the pathophysiology of PTB, but conflicting results in recent years have raised doubts. We conducted a study of PTB compared with term birth in two cohorts of pregnant women: one predominantly Caucasian (n = 39) at low risk for PTB, the second predominantly African American and at high-risk (n = 96). We profiled the taxonomic composition of 2,179 vaginal swabs collected prospectively and weekly during gestation using 16S rRNA gene sequencing. Previously proposed associations between PTB and lower Lactobacillus and higher Gardnerella abundances replicated in the low-risk cohort, but not in the high-risk cohort. High-resolution bioinformatics enabled taxonomic assignment to the species and subspecies levels, revealing that Lactobacillus crispatus was associated with low risk of PTB in both cohorts, while Lactobacillus iners was not, and that a subspecies clade of Gardnerella vaginalis explained the genus association with PTB. Patterns of cooccurrence between L. crispatus and Gardnerella were highly exclusive, while Gardnerella and L. iners often coexisted at high frequencies. We argue that the vaginal microbiota is better represented by the quantitative frequencies of these key taxa than by classifying communities into five community state types. Our findings extend and corroborate the association between the vaginal microbiota and PTB, demonstrate the benefits of high-resolution statistical bioinformatics in clinical microbiome studies, and suggest that previous conflicting results may reflect the different risk profile of women of black race.
- Published
- 2017
222. Numerous uncharacterized and highly divergent microbes which colonize humans are revealed by circulating cell-free DNA
- Author
-
Stephen R. Quake, Nathan D. Wolfe, Iwijn De Vlaminck, David K. Stevenson, Jennifer Okamoto, Norma F. Neff, Wenying Pan, Ronald J. Wong, Lance Martin, Winston Koh, Yasser Y. El-Sayed, Michael Kertesz, Sandhya Kharbanda, Joan Camunas-Soler, Gary M. Shaw, Yair J. Blumenfeld, and Mark Kowarsky
- Subjects
0301 basic medicine ,Genetics ,DNA, Bacterial ,Multidisciplinary ,Contig ,Shotgun sequencing ,Microbiota ,Human microbiome ,Genetic Variation ,High-Throughput Nucleotide Sequencing ,Biological dark matter ,Biology ,Biological Sciences ,Circulating Cell-Free DNA ,03 medical and health sciences ,030104 developmental biology ,Metagenomics ,Evolutionary biology ,Phylogenetics ,DNA, Viral ,Humans ,Microbiome ,Cell-Free Nucleic Acids ,Phylogeny - Abstract
Blood circulates throughout the human body and contains molecules drawn from virtually every tissue, including the microbes and viruses which colonize the body. Through massive shotgun sequencing of circulating cell-free DNA from the blood, we identified hundreds of new bacteria and viruses which represent previously unidentified members of the human microbiome. Analyzing cumulative sequence data from 1,351 blood samples collected from 188 patients enabled us to assemble 7,190 contiguous regions (contigs) larger than 1 kbp, of which 3,761 are novel with little or no sequence homology in any existing databases. The vast majority of these novel contigs possess coding sequences, and we have validated their existence both by finding their presence in independent experiments and by performing direct PCR amplification. When their nearest neighbors are located in the tree of life, many of the organisms represent entirely novel taxa, showing that microbial diversity within the human body is substantially broader than previously appreciated.
- Published
- 2017
223. Point-of-Care Fecal Calprotectin Monitoring in Preterm Infants at Risk for Necrotizing Enterocolitis
- Author
-
Megan Christofferson, Henry C. Lee, Karl G. Sylvester, David K. Stevenson, Warapan Nakayuenyongsuk, and K.T. Park
- Subjects
Male ,medicine.medical_specialty ,Birth weight ,Point-of-Care Systems ,Gastroenterology ,Infant, Newborn, Diseases ,Preeclampsia ,Cohort Studies ,03 medical and health sciences ,Feces ,fluids and secretions ,0302 clinical medicine ,Enterocolitis, Necrotizing ,030225 pediatrics ,Internal medicine ,Medicine ,Birth Weight ,Humans ,Infant, Very Low Birth Weight ,Prospective Studies ,business.industry ,Infant, Newborn ,medicine.disease ,Pediatrics, Perinatology and Child Health ,Necrotizing enterocolitis ,Cohort ,Etiology ,030211 gastroenterology & hepatology ,Female ,Calprotectin ,business ,Leukocyte L1 Antigen Complex ,Biomarkers ,Infant, Premature ,Cohort study - Abstract
To establish baseline trends in fecal calprotectin, a protein excreted into the stool when there is neutrophilic inflammation in the bowel, in infants at risk for necrotizing enterocolitis (NEC).We performed a prospective observational cohort study in infants with a birth weight of1500 g without existing bowel disease at a level IV neonatal intensive care unit from October 2015 to September 2016. Stools were collected once daily for 30 days or until 32 weeks postmenstrual age and processed using the Fecal Calprotectin High Range Quantitative Quantum Blue assay.In 64 preterm infants, during the first week after birth, 62% of infants had an initial stool sample with high baseline calprotectin levels (≥200 µg/g). In assessment of maternal and neonatal risk factors, maternal etiology for preterm birth (ie, eclamplsia or preeclampsia) was the only significant factor associated with high baseline calprotectin level. Two patients in the cohort developed NEC. Calprotectin levels for the entire cohort fluctuated during the observed period but generally increased in the third and fourth weeks after birth.At-risk infants had highly variable fecal calprotectin levels, with maternal causes for preterm birth associated with higher baseline levels. More longitudinal data in infants with NEC are necessary to determine whether acute rises in fecal calprotectin levels prior to clinical diagnosis can be confirmed as a diagnostic or prognostic biomarker.
- Published
- 2017
224. The Importance of Hemolysis and Its Clinical Detection in Neonates with Hyperbilirubinemia
- Author
-
Ronald J. Wong, David K. Stevenson, and Vinod K. Bhutani
- Subjects
Pediatrics ,medicine.medical_specialty ,Bilirubin ,02 engineering and technology ,Disease ,Hemolysis ,Bilirubin binding ,Genetic profile ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,030225 pediatrics ,medicine ,Humans ,Hyperbilirubinemia ,business.industry ,Infant, Newborn ,Increased bilirubin ,Jaundice ,021001 nanoscience & nanotechnology ,medicine.disease ,Increased risk ,chemistry ,Pediatrics, Perinatology and Child Health ,medicine.symptom ,0210 nano-technology ,business - Abstract
Hyperbilirubinemia is a benign transitional phenomenon that occurs in 60% to 80% of all term infants. The degree of hyperbilirubinemia and hence risk for developing bilirubin-induced neurologic dysfunction or BIND is dependent upon two major processes: (i) bilirubin production and its elimination.The aim of this review is to address the importance of hemolysis and its clinical detection in neonates with hyperbilirubinemia.In newborns, an increased bilirubin production rate due to hemolysis is often the primary cause of hyperbilirubinemia during the first week of life. If undiagnosed or untreated, it may lead to an increased risk for BIND. Therefore, the ability to identify infants with hemolytic disease is important in assessing those at risk for developing BIND. In addition, an infant's genetic profile and bilirubin binding status can also affect their overall capacity to cope with the resultant tissue bilirubin load and affect risk and guide appropriate management strategies.Therefore, the determination of a newborn's bilirubin production rate is critical to the assessment of a newborn's risk for developing unpredictable extreme hyperbilirubinemia and preventing BIND.
- Published
- 2017
225. Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support
- Author
-
Jennifer James, David Munson, Sara B. DeMauro, John C. Langer, April R. Dworetz, Girija Natarajan, Margarita Bidegain, Christine A. Fortney, Ruth Seabrook, Betty R. Vohr, Jon E. Tyson, Edward F. Bell, Brenda B. Poindexter, Seetha Shankaran, Rosemary D. Higgins, Abhik Das, Barbara J. Stoll, Haresh Kirpalani, Michael S. Caplan, Abbot R. Laptook, Angelita M. Hensman, Elisa Vieira, Emilee Little, Robert Burke, Melinda Caskey, Katharine Johnson, Barbara Alksninis, Mary Lenore Keszler, Andrea M. Knoll, Theresa M. Leach, Elisabeth C. McGowan, Victoria E. Watson, Suzy Ventura, Michele C. Walsh, Avroy A. Fanaroff, Anna Marie Hibbs, Nancy S. Newman, Allison H. Payne, Deanne E. Wilson-Costello, Bonnie S. Siner, Monika Bhola, Gulgun Yalcinkaya, Harriet G. Friedman, William E. Truog, Eugenia K. Pallotto, Howard W. Kilbride, Cheri Gauldin, Anne Holmes, Kathy Johnson, Allison Knutson, Kurt Schibler, Barbara Alexander, Cathy Grisby, Teresa L. Gratton, Jean J. Steichen, Estelle E. Fischer, Lenora Jackson, Kristin Kirker, Greg Muthig, Stacey Tepe, Kimberly Yolton, Ronald N. Goldberg, C. Michael Cotten, Ricki F. Goldstein, William F. Malcolm, Patricia L. Ashley, Kimberley A. Fisher, Joanne Finkle, Kathryn E. Gustafson, Matthew M. Laughon, Carl L. Bose, Janice Bernhardt, Gennie Bose, Janice Wereszczak, David P. Carlton, Ellen C. Hale, Ira Adams-Chapman, Yvonne Loggins, Stephanie Wilson Archer, Gregory M. Sokol, Lu-Ann Papile, Leslie Dawn Wilson, Dianne E. Herron, Susan Gunn, Lucy Smiley, Abbey C. Hines, Leif D. Nelin, Sudarshan R. Jadcherla, Pablo J. Sánchez, Patricia Luzader, Gail E. Besner, Nehal A. Parikh, Dennis Wallace, Marie G. Gantz, Jamie E. Newman, Jeanette O'Donnell Auman, Margaret Crawford, Carolyn M. Petrie Huitema, Kristin M. Zaterka-Baxter, Krisa P. Van Meurs, David K. Stevenson, M. Bethany Ball, Susan R. Hintz, Melinda S. Proud, Barbara Bentley, Maria Elena DeAnda, Anne M. DeBattista, Beth Earhart, Lynne C. Huffman, Casey E. Krueger, Hali E. Weiss, Waldemar A. Carlo, Namasivayam Ambalavanan, Myriam Peralta-Carcelen, Monica V. Collins, Shirley S. Cosby, Fred J. Biasini, Kristen C. Johnston, Cryshelle S. Patterson, Vivien A. Phillips, Sally Whitley, Uday Devaskar, Meena Garg, Isabell B. Purdy, Teresa Chanlaw, Rachel Geller, Dan L. Ellsbury, Tarah T. Colaizy, Jane E. Brumbaugh, John A. Widness, Karen J. Johnson, Jacky R. Walker, Donia B. Campbell, Diane L. Eastman, Kristi L. Watterberg, Jean R. Lowe, Janell F. Fuller, Robin K. Ohls, Conra Backstrom Lacy, Andrea F. Duncan, Barbara Schmidt, Aasma S. Chaudhary, Soraya Abbasi, Toni Mancini, Judy C. Bernbaum, Marsha Gerdes, Hallam Hurt, Carl T. D'Angio, Ronnie Guillet, Satyan Lakshminrusimha, Anne Marie Reynolds, Rosemary L. Jensen, Joan Merzbach, Gary J. Myers, Ashley Williams, Kelley Yost, William Zorn, Karen Wynn, Deanna Maffett, Diane Prinzing, Julianne Hunn, Stephanie Guilford, Farooq Osman, Mary Rowan, Michael G. Sacilowski, Holly I.M. Wadkins, Melissa Bowman, Kathleen A. Kennedy, Julie Arldt-McAlister, Katrina Burson, Andrea Freeman Duncan, Carmen Garcia, Beverly Foley Harris, Janice John, Patrick M. Jones, Layne M. Lillie, Karen Martin, Sara C. Martin, Georgia E. McDavid, Shawna Rodgers, Saba Siddiki, Daniel Sperry, Patti L. Pierce Tate, Sharon L. Wright, Myra Wyckoff, Luc P. Brion, Diana M. Vasil, Lijun Chen, Roy J. Heyne, Sally S. Adams, Linda A. Madden, Elizabeth Heyne, Alicia Guzman, Lizette E. Torres, Catherine Twell Boatman, Athina Pappas, Rebecca Bara, Laura A. Goldston, John Barks, Mary Christensen, Stephanie Wiggins, and Diane White
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Palliative care ,Birth weight ,Decision Making ,Article ,03 medical and health sciences ,0302 clinical medicine ,Early onset sepsis ,030225 pediatrics ,Intensive care ,Infant Mortality ,Outcome Assessment, Health Care ,medicine ,Humans ,030212 general & internal medicine ,Registries ,Retrospective Studies ,business.industry ,Infant, Newborn ,Gestational age ,Infant ,medicine.disease ,Life Support Care ,Survival Rate ,Withholding Treatment ,Life support ,Pediatrics, Perinatology and Child Health ,Necrotizing enterocolitis ,Gestation ,Female ,Morbidity ,business ,Infant, Premature - Abstract
Objectives To describe the frequency of postnatal discussions about withdrawal or withholding of life-sustaining therapy (WWLST), ensuing WWLST, and outcomes of infants surviving such discussions. We hypothesized that such survivors have poor outcomes. Study design This retrospective review included registry data from 18 centers of the National Institute of Child Health and Human Development Neonatal Research Network. Infants born at 22-28 weeks of gestation who survived >12 hours during 2011-2013 were included. Regression analysis identified maternal and infant factors associated with WWLST discussions and factors predicting ensuing WWLST. In-hospital and 18- to 26-month outcomes were evaluated. Results WWLST discussions occurred in 529 (15.4%) of 3434 infants. These were more frequent at 22-24 weeks (27.0%) compared with 27-28 weeks of gestation (5.6%). Factors associated with WWLST discussion were male sex, gestational age (GA) of ≤24 weeks, birth weight small for GA, congenital malformations or syndromes, early onset sepsis, severe brain injury, and necrotizing enterocolitis. Rates of WWLST discussion varied by center (6.4%-29.9%) as did WWLST (5.2%-20.7%). Ensuing WWLST occurred in 406 patients; of these, 5 survived to discharge. Of the 123 infants for whom intensive care was continued, 58 (47%) survived to discharge. Survival after WWLST discussion was associated with higher rates of neonatal morbidities and neurodevelopmental impairment compared with babies for whom WWLST discussions did not occur. Significant predictors of ensuing WWLST were maternal age >25 years, necrotizing enterocolitis, and days on a ventilator. Conclusions Wide center variations in WWLST discussions occur, especially at ≤24 weeks GA. Outcomes of infants surviving after WWLST discussions are poor. Trial registration ClinicalTrials.gov : NCT00063063 .
- Published
- 2017
226. Heme Oxygenase Activity and Heme Binding in a Neonatal Mouse Model
- Author
-
David K. Stevenson, Stephanie Kourula, Joyce Ang, Flora Kalish, Peter Vandenabeele, Hui Zhao, Karl G. Sylvester, and Ronald J. Wong
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Heterozygote ,Erythrocytes ,Time Factors ,Heme binding ,Cell Survival ,Heme ,Hemolysis ,Lipid peroxidation ,Erythroblastosis, Fetal ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,0302 clinical medicine ,Hemopexin ,Internal medicine ,medicine ,Animals ,Genetic Predisposition to Disease ,Aspartate Aminotransferases ,Promoter Regions, Genetic ,Mice, Knockout ,biology ,Membrane Proteins ,Alanine Transaminase ,Methemalbumin ,Heme oxygenase ,Disease Models, Animal ,Oxidative Stress ,030104 developmental biology ,Endocrinology ,Phenotype ,chemistry ,Alanine transaminase ,Animals, Newborn ,Liver ,Pediatrics, Perinatology and Child Health ,Toxicity ,biology.protein ,NIH 3T3 Cells ,Lipid Peroxidation ,030217 neurology & neurosurgery ,Heme Oxygenase-1 ,Developmental Biology ,Protein Binding - Abstract
Background: Severe hemolytic disease of the newborn leads to the release of pro-oxidative free heme (FH). Heme oxygenase (HO) is primarily responsible for detoxifying FH. Objective: To investigate the protective effects of HO in a model of heme overload. Methods: For in vitro studies, NIH3T3 HO-1-luc cells were incubated with 10, 30, or 60 µM FH or methemalbumin (MHA). HO-1 promoter activity was assessed 3, 6, and 24 h after treatment. Cell survival was indexed by viability assays. For in vivo studies, 1- and 5-week-old wild-type (Wt) or HO-1-heterozygous (Het, HO-1+/-) mice were given 60 µmol FH or MHA/kg intraperitoneally. After 24 h, plasma aspartate aminotransferease (AST)/alanine transaminase (ALT) and hemopexin, liver HO activity, and lipid peroxidation (LP) were determined. Results: In HO-1-luc cells, HO-1 promoter activity peaked 6 h after incubation with 30 µM FH (1.6-fold) or 60 µM MHA (2.1-fold) over baseline. Twenty-four hours after exposure to 60 µM FH, a decrease in viability of 80% was found, compared with no decrease after exposure to 60 µM MHA. In 1-week-old Wt and HO-1 Het pups given 60 µmol FH/kg, HO activity significantly increased 3.5- and 3.1-fold, respectively. No changes in LP or AST/ALT levels were observed. In adult Wt and HO-1 Het mice, HO activity increased (3.0- and 2.6-fold, respectively). LP and AST levels significantly increased 28.4- and 2.7-fold, respectively, in adult HO-1 Het mice. Hemopexin levels at baseline were higher in adults compared with newborns for both Wt and Het mice. In addition, FH induced hemopexin levels in both adults and newborns, but to a lesser degree in newborns. Conclusions: FH is highly toxic in vitro, but its toxicity is abolished when bound to albumin. Newborns appear to be protected from the pro-oxidative effects of FH, which may be mediated by heme binding and a higher absolute HO activity at baseline and after FH-mediated induction.
- Published
- 2017
227. Antecedents and Outcomes of Abnormal Cranial Imaging in Moderately Preterm Infants
- Author
-
Namasivayam Ambalavanan, Sarah McGregor, Teresa Chanlaw, Abbot R. Laptook, Martin Keszler, Shampa Saha, Sudarshan R. Jadcherla, Stephanie A. Wiggins, Stephanie Guilford, Waldemar A. Carlo, Greg Muthig, Karen Martin, Michele C. Walsh, Patricia Luzader, Nehal A. Parikh, Nancy S. Newman, David P. Carlton, Carl T. D'Angio, Eugenia K. Pallotto, Rachel Geller, Richard A. Polin, Anne Holmes, Satyan Lakshminrusimha, Dennis Wallace, Holly I.M. Wadkins, Anna Marie Hibbs, Carl L. Bose, Jeanette O'Donnell Auman, Cindy Clark, Haresh Kirpalani, Girija Natarajan, Jodi A. Ulloa, Jon E. Tyson, Julie Arldt-McAlister, Barbara J. Stoll, Edward F. Bell, Ronald N. Goldberg, Yvonne Loggins, Marliese Dion Nist, Lenora Jackson, Jacky R. Walker, Jane E. Brumbaugh, Cheri Gauldin, John D.E. Barks, Rosemary L. Jensen, Donia B. Campbell, Rosemary D. Higgins, Bonnie S. Siner, Monica V. Collins, Toni Mancini, Ann Marie Scorsone, Janice Bernhardt, Seetha Shankaran, Kristin M. Zaterka-Baxter, Jennifer Fuller, Lizette E. Torres, Kathy Johnson, Karen J. Johnson, Luc P. Brion, Margaret M. Crawford, Leif D. Nelin, Diane I. Bottcher, Julianne Hunn, Carol Hartenberger, Carmen Garcia, M. Bethany Ball, Shirley S. Cosby, Marissa E. Jones, Matthew M. Laughon, Diane F. White, Barbara Alexander, Pablo J. Sánchez, Meena Garg, Uday Devaskar, Estelle E. Fischer, Ellen C. Hale, Sharon L. Wright, Athina Pappas, Conra Backstrom Lacy, Mary Christensen, Tarah T. Colaizy, David K. Stevenson, Lijun Chen, Shelley Handel, Rebecca Bara, Kristin Kirker, Melinda S. Proud, Dan L. Ellsbury, Betty R. Vohr, Sara B. DeMauro, Cathy Grisby, Robin K. Ohls, Tara Wolfe, Diana M. Vasil, Dara M. Cucinotta, Kimberley A. Fisher, Soraya Abbasi, Stephanie Wilson Archer, Joanne Finkle, Myra H. Wyckoff, Elisa Vieira, Suhas G. Kallapur, Dianne E. Herron, Jenna Gabrio, Howard W. Kilbride, Jennifer Jennings, Abhik Das, Julie Gutentag, Sandy Sundquist Beauman, Greg Sokol, Ashley Williams, Angelita M. Hensman, Krisa P. Van Meurs, Aasma S. Chaudhary, Georgia E. McDavid, Elizabeth Rodgers, and Sandra Wuertz
- Subjects
Adult ,medicine.medical_specialty ,Leukomalacia, Periventricular ,Resuscitation ,Gestational Age ,Antenatal steroid ,Article ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Neonatal Screening ,Pregnancy ,Risk Factors ,030225 pediatrics ,medicine ,Humans ,Prospective Studies ,Registries ,Obstetrics ,business.industry ,Cesarean Section ,Infant, Newborn ,Gestational age ,Brain ,Infant ,Stepwise regression ,medicine.disease ,Cystic Periventricular Leukomalacia ,Chorioamnionitis ,Logistic Models ,Pediatrics, Perinatology and Child Health ,Infant, Small for Gestational Age ,Gestation ,Small for gestational age ,Female ,business ,Intracranial Hemorrhages ,030217 neurology & neurosurgery ,Neonatal resuscitation ,Infant, Premature ,Ventriculomegaly ,Hydrocephalus - Abstract
OBJECTIVES: To describe the frequency and findings of cranial imaging in moderately preterm (MPT) infants (born at 29 0/7–33 6/7 weeks of gestation) across centers, and to examine the association between abnormal imaging and clinical characteristics. STUDY DESIGN: We used data from the Neonatal Research Network MPT Registry, including the most severe early (≤28 days) and late (>28 days) cranial imaging. Stepwise logistic regression and CART analysis were performed after adjustment for gestational age (GA), antenatal steroids and center. RESULTS: Among 7,021 infants, 4,184 (60%) underwent cranial imaging. These infants had lower GAs and birth weights and higher rates of birth weight small-for-gestation, outborn birth, cesarean delivery; neonatal resuscitation and treatment with surfactant, compared with those without imaging (P < .0001). Imaging abnormalities noted in 15% of the infants included any intracranial hemorrhage (13.2%), grades 3–4 intracranial hemorrhage (1.7%), cystic periventricular leukomalacia (2.6%) and ventriculomegaly (6.6%). Histological chorioamnionitis [OR 1.47; 95% C.I.:1.19–1.83], GA [0.95; 95% C.I.: 0.94–0.97], antenatal steroids [OR 0.55; 95% C.I.: 0.41–0.74] and cesarean delivery [OR 0.66; 95% C.I.: 0.53–0.81] were associated with abnormal imaging. The center with the highest rate of cranial imaging, compared with the lowest, had a higher risk of abnormal imaging [OR 2.08; 95% CI: 1.10–3.92]. On the CART model, cesarean delivery, center, antenatal steroids and chorioamnionitis, in that order, predicted abnormal imaging. CONCLUSIONS: Among the 60% of MPT infants with cranial imaging, 15% had intracranial hemorrhage, cystic periventricular leukomalacia or late ventriculomegaly. Further correlation of imaging and long-term neurodevelopmental outcomes in MPT infants is needed.
- Published
- 2017
228. Admission Temperature and Associated Mortality and Morbidity among Moderately and Extremely Preterm Infants
- Author
-
Abbot R. Laptook, Edward F. Bell, Seetha Shankaran, Nansi S. Boghossian, Myra H. Wyckoff, Sarah Kandefer, Michele Walsh, Shampa Saha, Rosemary Higgins, Richard A. Polin, Martin Keszler, Betty R. Vohr, Angelita M. Hensman, Elisa Vieira, Emilee Little, Avroy A. Fanaroff, Anna Marie Hibbs, Nancy S. Newman, Bonnie S. Siner, William E. Truog, Eugenia K. Pallotto, Howard W. Kilbride, Cheri Gauldin, Anne Holmes, Kathy Johnson, Kurt Schibler, Suhas G. Kallapur, Cathy Grisby, Barbara Alexander, Estelle E. Fischer, Lenora Jackson, Kristin Kirker, Jennifer Jennings, Sandra Wuertz, Greg Muthig, Edward F. Donovan, Jody Hessling, Marcia Worley Mersmann, Holly L. Mincey, C. Michael Cotten, Ronald N. Goldberg, Joanne Finkle, Kimberley A. Fisher, Kathy J. Auten, Matthew M. Laughon, Carl L. Bose, Janice Bernhardt, Cindy Clark, Barbara J. Stoll, David P. Carlton, Ellen C. Hale, Yvonne Loggins, Diane I. Bottcher, Stephanie Wilson Archer, Linda L. Wright, Elizabeth M. McClure, Brenda B. Poindexter, Gregory M. Sokol, Dianne E. Herron, James A. Lemons, Diana D. Appel, Lucy C. Miller, Pablo J. Sanchez, Leif D. Nelin, Sudarshan R. Jadcherla, Patricia Luzader, Nehal A. Parikh, Marliese Dion Nist, Jennifer Fuller, Julie Gutentag, Marissa E. Jones, Sarah McGregor, Elizabeth Rodgers, Jodi A. Ulloa, Tara Wolfe, Abhik Das, Dennis Wallace, W. Kenneth Poole, Kristin M. Zaterka-Baxter, Margaret Crawford, Jenna Gabrio, Jeanette O'Donnell Auman, Carolyn Petrie Huitema, Betty K. Hastings, Krisa P. Van Meurs, David K. Stevenson, M. Bethany Ball, Melinda S. Proud, Waldemar A. Carlo, Namasivayam Ambalavanan, Monica V. Collins, Shirley S. Cosby, Uday Devaskar, Meena Garg, Teresa Chanlaw, Rachel Geller, Tarah T. Colaizy, Dan L. Ellsbury, Jane E. Brumbaugh, Karen J. Johnson, Donia B. Campbell, Jacky R. Walker, Kristi L. Watterberg, Robin K. Ohls, Conra Backstrom Lacy, Sandra Sundquist Beauman, Carol Hartenberger, Barbara Schmidt, Haresh Kirpalani, Noah Cook, Sara B. DeMauro, Aasma S. Chaudhary, Soraya Abbasi, Toni Mancini, Dara Cucinotta, Carl T. D'Angio, Ronnie Guillet, Satyan Lakshminrusimha, Dale L. Phelps, Ann Marie Reynolds, Julianne Hunn, Rosemary Jensen, Holly I.M. Wadkins, Stephanie Guilford, Ashley Williams, Michael Sacilowski, Linda Reubens, Erica Burnell, Mary Rowan, Karen Wynn, Deanna Maffett, Luc P. Brion, Diana M. Vasil, Lijun Chen, Lizette E. Torres, Walid A. Salhab, Susie Madison, Gay Hensley, Nancy A. Miller, Alicia Guzman, Kathleen A. Kennedy, Jon E. Tyson, Julie Arldt-McAlister, Carmen Garcia, Karen Martin, Georgia E. McDavid, Sharon L. Wright, Esther G. Akpa, Patty A. Cluff, Anna E. Lis, Claudia I. Franco, Athina Pappas, John Barks, Rebecca Bara, Shelley Handel, Geraldine Muran, Diane F. White, Mary Christensen, and Stephanie A. Wiggins
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Fever ,Hospital mortality ,Hypothermia ,Infant, Premature, Diseases ,Logistic regression ,Child health ,Article ,Body Temperature ,03 medical and health sciences ,0302 clinical medicine ,Patient Admission ,Risk Factors ,030225 pediatrics ,Intensive Care Units, Neonatal ,Medicine ,Humans ,030212 general & internal medicine ,Hospital Mortality ,business.industry ,Extremely preterm ,Infant, Newborn ,Infant newborn ,United States ,Logistic Models ,Infant, Extremely Premature ,Pediatrics, Perinatology and Child Health ,Female ,business - Abstract
To evaluate the temperature distribution among moderately preterm (MPT, 29-33 weeks) and extremely preterm (EPT,29 weeks) infants upon neonatal intensive care unit (NICU) admission in 2012-2013, the change in admission temperature distribution for EPT infants between 2002-2003 and 2012-2013, and associations between admission temperature and mortality and morbidity for both MPT and EPT infants.Prospectively collected data from 18 centers in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network were used to examine NICU admission temperature of inborn MPT and EPT infants. Associations between admission temperature and mortality and morbidity were determined by multivariable logistic regression. EPT infants from 2002-2003 and 2012-2013 were compared.MPT and EPT cohorts consisted of 5818 and 3213 infants, respectively. The distribution of admission temperatures differed between the MPT vs EPT (P .01), including the percentage36.5°C (38.6% vs 40.9%), 36.5°C-37.5°C (57.3% vs 52.9%), and37.5°C (4.2% vs 6.2%). For EPT infants in 2012-2013 compared with 2002-2003, the percentage of temperatures between 36.5°C and 37.5°C more than doubled and the percentage of temperatures37.5°C more than tripled. Admission temperature was inversely associated with in-hospital mortality.Low and high admission temperatures are more frequent among EPT than MPT infants. Compared with a decade earlier, fewer EPT infants experience low admission temperatures but more have elevated temperatures. In spite of a change in distribution of NICU admission temperature, an inverse association between temperature and mortality risk persists.
- Published
- 2017
229. Fetal de novo mutations and preterm birth
- Author
-
Michael Snyder, David K. Stevenson, Gary M. Shaw, Jingjing Li, and John Oehlert
- Subjects
0301 basic medicine ,Cancer Research ,Maternal Health ,Organogenesis ,medicine.disease_cause ,Genome ,environment and public health ,Fetal Development ,Families ,Database and Informatics Methods ,Mice ,0302 clinical medicine ,Pregnancy ,Risk Factors ,Medicine and Health Sciences ,030212 general & internal medicine ,Copy-number variation ,Frameshift Mutation ,Children ,Genetics (clinical) ,Sequence Deletion ,Genetics ,Mutation ,Mammalian Genomics ,integumentary system ,Obstetrics and Gynecology ,Brain ,Genomics ,Genomic Databases ,3. Good health ,Deletion Mutation ,Cohort ,Premature Birth ,Female ,Infants ,Research Article ,lcsh:QH426-470 ,DNA Copy Number Variations ,macromolecular substances ,Biology ,Preterm Birth ,Research and Analysis Methods ,Frameshift mutation ,03 medical and health sciences ,Fetus ,medicine ,Animals ,Humans ,Molecular Biology ,Gene ,Ecology, Evolution, Behavior and Systematics ,Genome, Human ,Brain Development ,Biology and Life Sciences ,Computational Biology ,Genome Analysis ,Pregnancy Complications ,lcsh:Genetics ,030104 developmental biology ,Biological Databases ,Animal Genomics ,Age Groups ,People and Places ,Etiology ,Birth ,Women's Health ,Population Groupings ,Organism Development ,Developmental Biology - Abstract
Preterm birth (PTB) affects ~12% of pregnancies in the US. Despite its high mortality and morbidity, the molecular etiology underlying PTB has been unclear. Numerous studies have been devoted to identifying genetic factors in maternal and fetal genomes, but so far few genomic loci have been associated with PTB. By analyzing whole-genome sequencing data from 816 trio families, for the first time, we observed the role of fetal de novo mutations in PTB. We observed a significant increase in de novo mutation burden in PTB fetal genomes. Our genomic analyses further revealed that affected genes by PTB de novo mutations were dosage sensitive, intolerant to genomic deletions, and their mouse orthologs were likely developmentally essential. These genes were significantly involved in early fetal brain development, which was further supported by our analysis of copy number variants identified from an independent PTB cohort. Our study indicates a new mechanism in PTB occurrence independently contributed from fetal genomes, and thus opens a new avenue for future PTB research., Author summary Preterm birth is a prevalent pregnancy condition and leads to substantial morbidity and mortality. Its genetic association has been well observed, but the underlying etiology remains unclear. Current research has been focused on identifying risk factors in maternal genomes. In this study, we tested an unexplored hypothesis that preterm birth could be independently influenced by fetal genomes. We analyzed fetal de novo mutations, those not inherited from parents, from 816 trio families, and found preterm infants tended to have increased de novo mutation rates compared to infants born at term. Importantly, we also observed that these preterm-associated de novo mutations preferentially affect dosage sensitive genes that are essential in embryonic development, and these affected genes are involved in early fetal brain development. Overall, our study for the first time showed the fetal genetic contribution to preterm birth, and suggested abnormal fetal development as a potential cause for preterm birth.
- Published
- 2017
230. Humans are colonized by many uncharacterized and highly divergent microbes
- Author
-
David K. Stevenson, Norma F. Neff, Lance Martin, Mark Kowarsky, Wenying Pan, Yair J. Blumenfeld, Nathan D. Wolfe, Joan Camunas-Soler, Gary M. Shaw, Michael Kertesz, Stephen R. Quake, Sandhya Kharbanda, Ronald J. Wong, Iwijn De Vlaminck, Jennifer Okamoto, Lcw Koh, and Yasser Y. El-Sayed
- Subjects
Genetics ,Contig ,biology ,Shotgun sequencing ,Microbial diversity ,Human microbiome ,Tree of life ,biology.organism_classification ,law.invention ,chemistry.chemical_compound ,chemistry ,law ,Evolutionary biology ,Bacteria ,Polymerase chain reaction ,DNA - Abstract
Blood circulates throughout the entire body and contains molecules drawn from virtually every tissue, including the microbes and viruses which colonize the body. Through massive shotgun sequencing of circulating cell-free DNA from the blood, we identified hundreds of new bacteria and viruses which represent previously unidentified members of the human microbiome. Analysing cumulative sequence data from 1,351 blood samples collected from 188 patients enabled us to assemble 7,190 contiguous regions (contigs) larger than 1 kbp, of which 3,761 are novel with little or no sequence homology in any existing databases. The vast majority of these novel contigs possess coding sequences, and we have validated their existence both by finding their presence in independent experiments and by performing direct PCR amplification. When their nearest neighbors are located in the tree of life, many of the organisms represent entirely novel taxa, showing that microbial diversity within the human body is substantially broader than previously appreciated.
- Published
- 2017
- Full Text
- View/download PDF
231. What factors are related to recurrent preterm birth among underweight women?
- Author
-
Suzan L. Carmichael, Deirdre J. Lyell, Gary M. Shaw, Anna I. Girsen, Jonathan A. Mayo, David K. Stevenson, Matthew B. Wallenstein, and Jeffrey B. Gould
- Subjects
Adult ,medicine.medical_specialty ,Pediatrics ,genetic structures ,Adolescent ,Birth weight ,Birth certificate ,Article ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Thinness ,Pregnancy ,Recurrence ,Risk Factors ,Medicine ,Humans ,030212 general & internal medicine ,Retrospective Studies ,030219 obstetrics & reproductive medicine ,business.industry ,Obstetrics ,Infant, Newborn ,Obstetrics and Gynecology ,Pregnancy Complications ,Pediatrics, Perinatology and Child Health ,Premature Birth ,Female ,Underweight ,medicine.symptom ,business ,Body mass index ,High risk pregnancy - Abstract
Our objective was to identify factors associated with recurrent preterm birth among underweight women.Maternally linked hospital and birth certificate records of deliveries in California between 2007 and 2010 were used. Consecutive singleton pregnancies of women with underweight body mass index (BMI 18.5 kg/mWe analyzed 4971 women with underweight BMI in the first pregnancy. Of these, 670 had at least one preterm birth. Among these 670, 86 (21.8%) women experienced a recurrent preterm birth. Odds for first term - second preterm birth were decreased for increases in maternal age (aOR: 0.90, 95%CI: 0.95-0.99) whereas inter-pregnancy interval6 months was related to both first term - second preterm birth (aOR:1.66, 95%CI: 1.21-2.28) and first preterm birth - second term birth (aOR: 1.43, 95%CI: 1.04-1.96). Factors associated with recurrent preterm birth were: negative or no change in pre-pregnancy weight between pregnancies (aOR: 1.67, 95%CI: 1.07-2.60), inter-pregnancy interval 6 months (aOR: 2.14, 95%CI: 1.29-3.56), and maternal age in the first pregnancy (aOR: 0.93, 95%CI: 0.90-0.97).Recurrent preterm birth among underweight women was associated with younger age, short inter-pregnancy interval, and negative or no weight change between pregnancies.
- Published
- 2017
232. Maternal prepregnancy body mass index and risk of bronchopulmonary dysplasia
- Author
-
Peiyi Kan, Jeffrey B. Gould, Suzan L. Carmichael, Henry C. Lee, David K. Stevenson, and Gary M. Shaw
- Subjects
Adult ,Male ,medicine.medical_specialty ,Birth weight ,Maternal Health ,Gestational Age ,California ,Body Mass Index ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Pregnancy ,Risk Factors ,Intensive care ,Intensive Care Units, Neonatal ,mental disorders ,medicine ,Birth Weight ,Humans ,Infant, Very Low Birth Weight ,030212 general & internal medicine ,Obesity ,Prospective Studies ,Bronchopulmonary Dysplasia ,Inflammation ,030219 obstetrics & reproductive medicine ,Obstetrics ,business.industry ,Body Weight ,Infant, Newborn ,Gestational age ,Odds ratio ,medicine.disease ,Patient Discharge ,Oxygen ,Pregnancy Complications ,Bronchopulmonary dysplasia ,Pediatrics, Perinatology and Child Health ,Intensive Care, Neonatal ,Female ,Underweight ,medicine.symptom ,business ,Body mass index ,Infant, Premature - Abstract
BackgroundWe examined the relationship between women's prepregnancy BMI and development of bronchopulmonary dysplasia (BPD) in their preterm offspring, hypothesizing that obesity-associated inflammation may increase risk.MethodsWe studied infants born in California between 2007 and 2011, using linked data from California Perinatal Quality Care Collaborative neonatal intensive care units, hospital discharge, and vital statistics. We included infants with birthweight1,500 g or gestational age at birth of 22-29 weeks. BPD was defined as continuous supplemental oxygen use at 36 weeks' postmenstrual age.ResultsAmong 12,621 infants, 4,078 (32%) had BPD. After adjustment for maternal race/ethnicity, age, education, payer source, and infant sex, BMI status underweight I (BMI16.9, odds ratio (OR) 1.7, 95% confidence interval (CI) 1.3-2.1) and obesity III (BMI ⩾40.0, OR 1.3, 95% CI 1.0-1.6) were associated with an increased risk of BPD. When considering maternal BMI as a continuous variable, a nonlinear association with BPD was observed for male infants and infants delivered at 25-29 weeks of gestational age, but not for other subgroups.ConclusionBoth high and low maternal BMI were associated with increased BPD risk. These findings support the notion that BPD is a multi-factorial disease that may sometimes have its origins in utero and be influenced by maternal inflammation.
- Published
- 2017
233. Markers of Successful Extubation in Extremely Preterm Infants, and Morbidity After Failed Extubation
- Author
-
Sanjay Chawla, Girija Natarajan, Seetha Shankaran, Benjamin Carper, Luc P. Brion, Martin Keszler, Waldemar A. Carlo, Namasivayam Ambalavanan, Marie G. Gantz, Abhik Das, Neil Finer, Ronald N. Goldberg, C. Michael Cotten, Rosemary D. Higgins, Alan H. Jobe, Michael S. Caplan, Richard A. Polin, Abbot R. Laptook, William Oh, Angelita M. Hensman, Dan Gingras, Susan Barnett, Sarah Lillie, Kim Francis, Dawn Andrews, Kristen Angela, Michele C. Walsh, Avroy A. Fanaroff, Nancy S. Newman, Bonnie S. Siner, Kurt Schibler, Edward F. Donovan, Vivek Narendran, Kate Bridges, Barbara Alexander, Cathy Grisby, Marcia Worley Mersmann, Holly L. Mincey, Jody Hessling, Kathy J. Auten, Kimberly A. Fisher, Katherine A. Foy, Gloria Siaw, Barbara J. Stoll, Susie Buchter, Anthony Piazza, David P. Carlton, Ellen C. Hale, Stephanie Wilson Archer, Brenda B. Poindexter, James A. Lemons, Faithe Hamer, Dianne E. Herron, Lucy C. Miller, Leslie D. Wilson, Mary Anne Berberich, Carol J. Blaisdell, Dorothy B. Gail, James P. Kiley, W. Kenneth Poole, Margaret Cunningham, Betty K. Hastings, Amanda R. Irene, Jeanette O'Donnell Auman, Carolyn Petrie Huitema, James W. Pickett, Dennis Wallace, Kristin M. Zaterka-Baxter, Krisa P. Van Meurs, David K. Stevenson, M. Bethany Ball, Melinda S. Proud, Ivan D. Frantz, John M. Fiascone, Anne Furey, Brenda L. MacKinnon, Ellen Nylen, Monica V. Collins, Shirley S. Cosby, Vivien A. Phillips, Maynard R. Rasmussen, Paul R. Wozniak, Wade Rich, Kathy Arnell, Renee Bridge, Clarence Demetrio, Edward F. Bell, John A. Widness, Jonathan M. Klein, Karen J. Johnson, Shahnaz Duara, Ruth Everett-Thomas, Kristi L. Watterberg, Robin K. Ohls, Julie Rohr, Conra Backstrom Lacy, Dale L. Phelps, Nirupama Laroia, Linda J. Reubens, Erica Burnell, Pablo J. Sánchez, Charles R. Rosenfeld, Walid A. Salhab, James Allen, Alicia Guzman, Gaynelle Hensley, Melissa H. Lepps, Melissa Martin, Nancy A. Miller, Araceli Solis, Diana M. Vasil, Kerry Wilder, Kathleen A. Kennedy, Jon E. Tyson, Brenda H. Morris, Beverly Foley Harris, Anna E. Lis, Sarah Martin, Georgia E. McDavid, Patti L. Tate, Sharon L. Wright, Bradley A. Yoder, Roger G. Faix, Jill Burnett, Jennifer J. Jensen, Karen A. Osborne, Cynthia Spencer, Kimberlee Weaver-Lewis, T. Michael O'Shea, Nancy J. Peters, Beena G. Sood, Rebecca Bara, Elizabeth Billian, Mary Johnson, Richard A. Ehrenkranz, Harris C. Jacobs, Vineet Bhandari, Pat Cervone, Patricia Gettner, Monica Konstantino, JoAnn Poulsen, and Janet Taft
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Positive pressure ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,030225 pediatrics ,Fraction of inspired oxygen ,medicine ,Intubation ,Humans ,030212 general & internal medicine ,Continuous positive airway pressure ,Treatment Failure ,Respiratory Distress Syndrome, Newborn ,business.industry ,Infant, Newborn ,Gestational age ,Pulmonary Surfactants ,medicine.disease ,Surgery ,Bronchopulmonary dysplasia ,Anesthesia ,Infant, Extremely Premature ,Pediatrics, Perinatology and Child Health ,Airway Extubation ,Apgar score ,Female ,Morbidity ,business ,Infant, Premature - Abstract
Objectives To identify variables associated with successful elective extubation, and to determine neonatal morbidities associated with extubation failure in extremely preterm neonates. Study design This study was a secondary analysis of the National Institute of Child Health and Human Development Neonatal Research Network's Surfactant, Positive Pressure, and Oxygenation Randomized Trial that included extremely preterm infants born at 240/7 to 276/7 weeks' gestation. Patients were randomized either to a permissive ventilatory strategy (continuous positive airway pressure group) or intubation followed by early surfactant (surfactant group). There were prespecified intubation and extubation criteria. Extubation failure was defined as reintubation within 5 days of extubation. Results Of 1316 infants in the trial, 1071 were eligible; 926 infants had data available on extubation status; 538 were successful and 388 failed extubation. The rate of successful extubation was 50% (188/374) in the continuous positive airway pressure group and 63% (350/552) in the surfactant group. Successful extubation was associated with higher 5-minute Apgar score, and pH prior to extubation, lower peak fraction of inspired oxygen within the first 24 hours of age and prior to extubation, lower partial pressure of carbon dioxide prior to extubation, and non-small for gestational age status after adjustment for the randomization group assignment. Infants who failed extubation had higher adjusted rates of mortality (OR 2.89), bronchopulmonary dysplasia (OR 3.06), and death/ bronchopulmonary dysplasia (OR 3.27). Conclusions Higher 5-minute Apgar score, and pH prior to extubation, lower peak fraction of inspired oxygen within first 24 hours of age, lower partial pressure of carbon dioxide and fraction of inspired oxygen prior to extubation, and nonsmall for gestational age status were associated with successful extubation. Failed extubation was associated with significantly higher likelihood of mortality and morbidities. Trial registration ClinicalTrials.gov : NCT00233324 .
- Published
- 2017
234. Risk for spontaneous preterm birth among inter-racial/ethnic couples*
- Author
-
Gary M. Shaw, Deirdre J. Lyell, Jonathan A. Mayo, Yair J. Blumenfeld, Bat Zion Shachar, and David K. Stevenson
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Ethnic group ,California ,Cohort Studies ,Young Adult ,03 medical and health sciences ,Race (biology) ,0302 clinical medicine ,Pregnancy ,Risk Factors ,Ethnicity ,Odds Ratio ,medicine ,Humans ,030212 general & internal medicine ,030219 obstetrics & reproductive medicine ,Obstetrics ,business.industry ,Infant, Newborn ,Obstetrics and Gynecology ,Middle Aged ,Racial ethnic ,Logistic Models ,Variation (linguistics) ,Pediatrics, Perinatology and Child Health ,Premature Birth ,Female ,business ,Demography - Abstract
Objective: Approximately 10% of US couples are inter-racial/ethnic. Substantial variation in preterm birth (PTB) rates is seen when stratified by race/ethnicity, although most studies focused solely on maternal racial/ethnic demographics. Our aims were to analyze the contribution of paternal in addition to maternal race/ethnicity, and to evaluate risk of spontaneous PTB for previously understudied inter-racial/ethnic couples. Methods: California singleton live births from 2007 to 2010 were included. Race/ethnicity was determined based on self-report, obtained from birth certificates and defined as African American (AA), Hispanic, Asian, and White. Logistic regression was used to estimate odds ratios of spontaneous PTB at 20–23, 24–31, 32–36 and Results: Among 1,664,939 live births, 13% (n = 216,417) were born to inter-racial/ethnic couples. Compared to White–White couples, risk for spontaneous PTB was increased across all inter-racial/ethnic couples with a non-White mother, except when the father was Asian. Patterns of association were similar after stratification by previous PTB, hypertension and diabetes. Paternal race/ethnicity was also a significant risk factor for PTB. Conclusions: Increased risks for spontaneous PTB were seen in most inter-racial/ethnic couple groupings. In addition to maternal race/ethnicity, paternal race/ethnicity was a significant risk factor in many inter-racial/ethnic couplings. Identifying such different risk profiles based on both maternal and paternal race/ethnicity may offer new lines of research inquiry for the underlying etiologies of PTB.
- Published
- 2017
- Full Text
- View/download PDF
235. An immune clock of human pregnancy
- Author
-
Maurice L. Druzin, Gary L. Darmstadt, Sofie Van Gassen, Martha Tingle, Virginia D. Winn, David K. Stevenson, Quentin Baca, Robin Okada, Nima Aghaeepour, Garry P. Nolan, Leslie McNeil, David B. Lewis, Ronald J. Wong, David Furman, Yaser Y. El-Sayed, Amy S. Tsai, Martin S. Angst, Mohammad Sajjad Ghaemi, Robert Tibshirani, Edward A. Ganio, Ronald S. Gibbs, Gary M. Shaw, Brice Gaudilliere, David R. McIlwain, Dyani Gaudilliere, and Cecele C. Quaintance
- Subjects
0301 basic medicine ,Elastic net regularization ,Cell signaling ,T cell ,Immunology ,Computational biology ,Biology ,Bioinformatics ,INFLUENZA-A VIRUS ,PHENOTYPE ,DENDRITIC CELLS ,ACTIVATION ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,medicine ,Medicine and Health Sciences ,Mass cytometry ,REGULATORY T-CELLS ,TOLL-LIKE RECEPTORS ,Pregnancy ,Term pregnancy ,Biology and Life Sciences ,General Medicine ,medicine.disease ,MASS CYTOMETRY ,3. Good health ,030104 developmental biology ,medicine.anatomical_structure ,Mathematics and Statistics ,HEALTH ,Signal transduction ,NK CELLS ,030217 neurology & neurosurgery ,RESPONSES - Abstract
The maintenance of pregnancy relies on finely tuned immune adaptations. We demonstrate that these adaptations are precisely timed, reflecting an immune clock of pregnancy in women delivering at term. Using mass cytometry, the abundance and functional responses of all major immune cell subsets were quantified in serial blood samples collected throughout pregnancy. Cell signaling-based Elastic Net, a regularized regression method adapted from the elastic net algorithm, was developed to infer and prospectively validate a predictive model of interrelated immune events that accurately captures the chronology of pregnancy. Model components highlighted existing knowledge and revealed previously unreported biology, including a critical role for the interleukin-2-dependent STAT5ab signaling pathway in modulating T cell function during pregnancy. These findings unravel the precise timing of immunological events occurring during a term pregnancy and provide the analytical framework to identify immunological deviations implicated in pregnancy-related pathologies.
- Published
- 2017
236. Risk of recurrent preterm birth among women according to change in partner
- Author
-
Audrey F. Saftlas, Christina D. Chambers, Chris Dunkel Schetter, Juan Yang, Vincenzo Berghella, Gary M. Shaw, Kelli K. Ryckman, Rebecca J. Baer, Laura L. Jelliffe-Pawlowski, and David K. Stevenson
- Subjects
Reproductive health and childbirth ,Low Birth Weight and Health of the Newborn ,California ,interpregnancy interval ,0302 clinical medicine ,early term birth ,Pregnancy ,Infant Mortality ,030212 general & internal medicine ,Young adult ,skin and connective tissue diseases ,Pediatric ,education.field_of_study ,030219 obstetrics & reproductive medicine ,Obstetrics ,Obstetrics and Gynecology ,Sexual Partners ,recurrent preterm birth ,Premature birth ,Premature Birth ,Female ,Adult ,medicine.medical_specialty ,Adolescent ,Adverse pregnancy outcome ,Population ,Clinical Sciences ,change in partner ,Article ,Preeclampsia ,Paediatrics and Reproductive Medicine ,03 medical and health sciences ,Young Adult ,Preterm ,Clinical Research ,medicine ,Humans ,education ,Spouses ,Obstetrics & Reproductive Medicine ,Retrospective Studies ,multipartner fertility ,business.industry ,Prevention ,Contraception/Reproduction ,preterm birth ,Retrospective cohort study ,Odds ratio ,Perinatal Period - Conditions Originating in Perinatal Period ,medicine.disease ,Confidence interval ,Good Health and Well Being ,Pediatrics, Perinatology and Child Health ,sense organs ,business - Abstract
There is well-established literature indicating change in partner as a risk for preeclampsia, yet the research on the risk of preterm birth after a change in partners has been sparse and inconsistent. Using a population of California live born singletons, we aimed to determine the risk of preterm birth after a change in partner between the first and second pregnancies. The risk of preterm and early term delivery in the second pregnancy was calculated for mothers who did or did not change partners between births with the referent group as women who delivered both pregnancies at term and did not change partners. Adjusted odds ratios (ORs) and their 95% confidence intervals (CIs) were calculated. Relative to women who delivered at 39 weeks or later in the second pregnancy and did not change partners, preterm birth risks were somewhat lower for women who changed partners between the first and second pregnancies compared to those women who did not change partners. For example, 10.6% of women who did not change partners and delivered their second pregnancy before 34 weeks also delivered their first pregnancy before 34 weeks, while 8.5% of women who changed partners delivered before 34 weeks. Findings suggest partner change may alter the risk of preterm birth.
- Published
- 2017
237. Nulliparous teenagers and preterm birth in California
- Author
-
David K. Stevenson, Jonathan A. Mayo, Bat Zion Shachar, and Gary M. Shaw
- Subjects
medicine.medical_specialty ,Adolescent ,Population ,Prenatal care ,Birth certificate ,California ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,Humans ,Medicine ,030212 general & internal medicine ,education ,Teenage pregnancy ,education.field_of_study ,030219 obstetrics & reproductive medicine ,business.industry ,Obstetrics ,Obstetrics and Gynecology ,Retrospective cohort study ,Odds ratio ,Parity ,Pregnancy in Adolescence ,Pediatrics, Perinatology and Child Health ,Premature Birth ,Gestation ,Female ,business ,Maternal Age ,Cohort study - Abstract
Background:Young maternal age is one of the numerous risk factors for delivery before 37 weeks of gestation, yet the mechanisms are unclear. The purpose of the current study was to investigate the association between teenagers and the risk of preterm birth (PTB) in a large and recent cohort study.Methods:We conducted a population-based retrospective cohort study using 2007–2011 California birth certificate records linked with hospital discharge indices and United States census data for nulliparous 13–20 year olds who gave birth to singletons. Maternal age was examined categorically at 1 year intervals. PTB was defined as delivery at Results:The prevalence of PTB was highest among the youngest (13 year olds, 14.5%) and lowest among the oldest (20 year olds, 6.7%). After adjusting for maternal and paternal race/ethnicity, paternal age, initiation of prenatal care, source of payment, pre-pregnancy body-mass-index (BMI), height, smoking, and poverty; young mothers of ages 13, 14, 15, and 16 years had increased odds for spontaneous PTB at Conclusions:Nulliparous teenagers were at increased risk for spontaneous PTB, especially those 16 years or younger. Medically indicated PTB was not associated with young age.
- Published
- 2017
238. Copy number variation in bronchopulmonary dysplasia
- Author
-
Jeffrey B. Gould, John S. Witte, Cecele C. Quaintance, David K. Stevenson, John Oehlert, Laura L. Jelliffe-Pawlowski, Gary M. Shaw, Hui Wang, Thomas J. Hoffmann, and Hugh O'Brodovich
- Subjects
Pediatrics ,medicine.medical_specialty ,DNA Copy Number Variations ,Extramural ,business.industry ,Infant, Newborn ,MEDLINE ,Case-control study ,medicine.disease ,Infant newborn ,Article ,Bronchopulmonary dysplasia ,Case-Control Studies ,Genetics ,medicine ,Humans ,Copy-number variation ,business ,Genetics (clinical) ,Bronchopulmonary Dysplasia - Published
- 2014
239. Maternal Prepregnancy Body Mass Index and Risk of Spontaneous Preterm Birth
- Author
-
David K. Stevenson, Bat Zion Shachar, Gary M. Shaw, Paul H. Wise, Suzan L. Carmichael, Deirdre J. Lyell, Kathryn Melsop, Jeffrey B. Gould, Julie Parsonnet, Catherine Ley, Jonathan A. Mayo, and Ciaran S. Phibbs
- Subjects
Pregnancy ,medicine.medical_specialty ,Epidemiology ,business.industry ,Obstetrics ,Gestational age ,Prenatal care ,Overweight ,medicine.disease ,Relative risk ,Pediatrics, Perinatology and Child Health ,Gestation ,Medicine ,medicine.symptom ,Underweight ,business ,Body mass index - Abstract
Background Findings from studies examining risk of preterm birth associated with elevated prepregnancy body mass index (BMI) have been inconsistent. Methods Within a large population-based cohort, we explored associations between prepregnancy BMI and spontaneous preterm birth across a spectrum of BMI, gestational age, and racial/ethnic categories. We analysed data for 989 687 singleton births in California, 2007–09. Preterm birth was grouped as 20–23, 24–27, 28–31, or 32–36 weeks gestation (compared with 37–41 weeks). BMI was categorised as
- Published
- 2014
240. Fellowship Program Directors Perspectives on Fellowship Training
- Author
-
Gail A. McGuinness, David K. Stevenson, Gary L. Freed, Lauren M. Moran, Laura Spera, and Kelly M. Dunham
- Subjects
Response rate (survey) ,Medical education ,Quality management ,business.industry ,Clinical training ,Pediatrics, Perinatology and Child Health ,Training time ,Career path ,Mail survey ,Medicine ,Subspecialty ,business ,Fellowship training - Abstract
BACKGROUND: Recently the American Board of Pediatrics has undertaken an effort to examine the components and structure of pediatric fellowship training. To provide the current status of training programs and the perspectives of those in positions of leadership regarding fellowship training, a study of all fellowship program directors in the United States was undertaken. METHODS: We conducted a mail survey of all 719 pediatric fellowship program directors in the United States. RESULTS: The response rate was 82.2%. Fellowship directors were almost evenly divided regarding whether they believe that there is a need to change the expected amount of clinical training time in their own subspecialty, with 51% stating the amount was appropriate and 48% believing it should be increased. Fewer than half (42%) of program directors believe that the amount of scholarly training time should be the same for all fellows in their subspecialty regardless of career path (ie, primarily clinical versus primarily research). The majority (58%) stated that regardless of career path, the required training for all fellows in their own subspecialty should remain 3 years. Only one-third of program directors strongly believed that quality improvement activities were an important component of fellowship training. CONCLUSIONS: Variation exists among fellowship program directors in their perceptions of the goals and structure of fellowship training. Determining the best way to both account for and recognize the specific nuances of each subspecialty, while maintaining a common set of standards for the profession, will be an important and ongoing effort into the future.
- Published
- 2014
241. The Initiative on Subspecialty Clinical Training and Certification (SCTC): Background and Recommendations
- Author
-
John D. Bancroft, Theodore C. Sectish, Eric S. Holmboe, Marshall L. Land, Victoria F. Norwood, Debra Boyer, Daniel J. Schumacher, Daniel C. West, Joseph W. St. Geme, Sarah S. Long, Gail A. McGuinness, Alan R. Cohen, Joseph T. Gilhooly, David K. Stevenson, M. Douglas Jones, and Mary Fran Hazinski
- Subjects
Medical education ,medicine.medical_specialty ,business.industry ,media_common.quotation_subject ,education ,Graduate medical education ,Certification ,Subspecialty ,Maintenance of Certification ,Excellence ,Family medicine ,Pediatrics, Perinatology and Child Health ,Medicine ,Professional association ,business ,Competence (human resources) ,Accreditation ,media_common - Abstract
* Abbreviations: ABP — : American Board of Pediatrics ABMS — : American Board of Medical Specialties ACGME — : Accreditation Council for Graduate Medical Education CBME — : competency-based medical education EPA — : entrustable professional activity FOPO — : Federation of Pediatric Organizations MOC — : Maintenance of Certification SCTC — : Subspecialty Clinical Training and Certification The American Board of Pediatrics (ABP) certifies general pediatricians and pediatric subspecialists based on standards of excellence that lead to high-quality health care during infancy, childhood, adolescence, and the transition into adulthood. Thus, central to the ABP’s mission is assurance to the public that a general pediatrician or pediatric subspecialist has successfully completed accredited training and fulfills the continuous evaluation requirements that encompass the 6 core competencies of the Accreditation Council for Graduate Medical Education (ACGME) and the American Board of Medical Specialties (ABMS). The ABP’s quest for excellence is evident in its rigorous evaluation process and in new initiatives undertaken that not only continually improve the standards of its certification but also advance the science, education, study, and practice of pediatrics. The ABP’s responsibilities and authorities in standard setting and evaluation overlap through interest and influence the responsibilities and authorities assumed by the ACGME through its Pediatric Review Committee in the area of training, as well as those of the American Academy of Pediatrics and the subspecialty societies with respect to advocacy and education. Although the respective organizations have distinct missions and roles, they often work in collaboration and synergy regarding training and advocacy. Nonetheless, standard setting, evaluation, and certification remain the sole purview of the ABP. Because of the centrality of accredited training to certification, a decision by the ABP to offer a subspecialty certificate leads to a petition to the ACGME to accredit training programs. The ABP provides substantial input to the development of initial subspecialty program requirements and periodic revisions through its respective subboards, and the ABP standards for certification heavily influence the content of program requirements. In the late 1990s, the ACGME and ABMS introduced the concept of competency-based medical education (CBME) with the establishment of 6 domains of competence: patient care, medical knowledge, practice-based … Address correspondence to David K. Stevenson, MD, Harold K. Faber Professor of Pediatrics, Stanford University School of Medicine, Medical School Office Building, 1265 Welch Rd, X157, Stanford, CA 94305. E-mail: dstevenson{at}stanford.edu
- Published
- 2014
242. Pediatric Subspecialty Fellowship Clinical Training Project: Recent Graduates and Midcareer Survey Comparison
- Author
-
Lauren M. Moran, Kelly M. Dunham, Gary L. Freed, David K. Stevenson, Laura Spera, and Gail A. McGuinness
- Subjects
medicine.medical_specialty ,Medical education ,Task force ,business.industry ,Family medicine ,Clinical training ,Pediatrics, Perinatology and Child Health ,Medicine ,business ,Subspecialty ,Fellowship training - Abstract
BACKGROUND:The American Board of Pediatrics charged a task force to examine fellowship training. As part of that process, a study was conducted to assess the perceptions of fellowship training by those who had recently completed training and those who were in the middle of their careers.METHODS:The American Board of Pediatrics provided a random sample of subspecialists stratified across all 14 subspecialties (N = 5072). Subspecialists were identified either as recent graduates (N = 2702), those who had completed fellowship within the last 5 years or as midcareer subspecialists (N = 2370), and those who completed fellowship 15 to 20 years ago. Two distinct 20-item structured questionnaires were administered by mail, 1 for each group, in January through March 2012. χ2 Statistics were used to assess differences between groups.RESULTS:Response rates were 77.8% for recent graduates and 73.8% for midcareer subspecialists. Overall, most subspecialists described their work primarily as a clinician (36%) or as a clinician-educator (48%). Fewer (12%) reported primarily research. The majority of subspecialists (55%) have full-time academic appointments, but recent graduates are more likely to do so than midcareer subspecialists (62% vs 48%; P < .0001). The majority (60%) believe that the overall length of training in their subspecialty should remain at 3 years. However, almost one-third (29%) believe there should be 2 different tracks in their subspecialty, shorter for clinicians and/or clinician-educators and longer for those pursuing an academic career.CONCLUSIONS:We found a significant range of opinion regarding subspecialty training. Some of this variation is undoubtedly due to differences between the individual subspecialties.
- Published
- 2014
243. Pediatric Subspecialty Fellowship Clinical Training Project: Current Fellows
- Author
-
Gary L. Freed, Gail A. McGuinness, Kelly M. Dunham, Laura Spera, Lauren M. Moran, and David K. Stevenson
- Subjects
medicine.medical_specialty ,Medical education ,business.industry ,Subspecialty ,Core curriculum ,Health care delivery ,Scholarship ,Clinical training ,Family medicine ,Pediatrics, Perinatology and Child Health ,Health care ,medicine ,Oversight Committee ,business ,Fellowship training - Abstract
BACKGROUND:The American Board of Pediatrics certifies physicians in general pediatrics and 14 pediatric subspecialties. Historically, all subspecialties have a standard pathway of training that is 3 years in duration to ensure time for both clinical and scholarly training and experience. In 2004, the American Board of Pediatrics expanded the scope for scholarly activity in fellowship training to include the assignment of each fellow to a Scholarship Oversight Committee and the completion of a scholarly activities core curriculum across subspecialties.METHODS:We conducted a national survey of all current fellows in 13 pediatric subspecialties who took the subspecialty in-training examination (N = 3551). Overall, 86% of all pediatric fellows in the United States sit for the examination.RESULTS:The majority (65%; N = 2178) believe the minimum 12-month expectation for clinical training is appropriate for their specific subspecialty. The majority of fellows (59%; N = 1984) do not agree that the amount of scholarly activity should be the same for all fellows in their respective subspecialties regardless of career path (ie, primarily clinical versus primarily research). Half (50%; N = 1661) posited that the required duration of training, regardless of career path, should remain at 3 years.CONCLUSIONS:Balancing the components of subspecialty training is an important and probably never-ending quest. As changes in the health care system and care delivery organization continue, what we expect and need from our subspecialists, from the perspectives of the profession, the health care delivery system, and the public, will probably vary over time.
- Published
- 2014
244. Assessing the Vulnerability of Marine Benthos to Fishing Gear Impacts
- Author
-
Steve Eayrs, David K. Stevenson, Bradley P. Harris, Chad Demarest, David B. Packer, Michelle Bachman, Vincent Malkoski, and Jonathan H. Grabowski
- Subjects
Engineering ,biology ,business.industry ,Fishing ,Vulnerability ,Management, Monitoring, Policy and Law ,Aquatic Science ,Otter ,Fishery ,Benthos ,Habitat ,Vulnerability assessment ,Benthic zone ,biology.animal ,Fisheries management ,business ,Ecology, Evolution, Behavior and Systematics - Abstract
The Magnuson-Stevens Fishery Conservation and Management Act (MSA) requires US fishery management plans to minimize, to the extent practicable, the adverse effects of fishing on essential fish habitats (EFHs). To meet this requirement, fishery managers would ideally be able to quantify such effects and visualize their distributions across space and time. Here, we develop a framework to quantify and assess benthic impacts of the six most common bottom-tending gears (>99% of bottom-tending fishing effort) in New England: otter trawls, scallop dredges, hydraulic clam dredges, gillnets, longlines, and traps. We first conducted a comprehensive review of the habitat impacts literature relevant to Northeast USA fishing gears and seabed types. We then used this information to develop a framework for generating and organizing quantitative susceptibility (based on percent loss of structural habitat from a single interaction with the gear) and recovery (i.e., the time required for recovery of lost structure) paramet...
- Published
- 2014
245. Swedish and American studies show that initiatives to decrease maternal obesity could play a key role in reducing preterm birth
- Author
-
Jonathan A. Mayo, Jeffrey B. Gould, David K. Stevenson, and Gary M. Shaw
- Subjects
Fetal Membranes, Premature Rupture ,medicine.medical_specialty ,Birth weight ,California ,Body Mass Index ,Pregnancy ,Risk Factors ,Humans ,Medicine ,American studies ,Obesity ,Preterm delivery ,Sweden ,business.industry ,Obstetrics ,Pregnancy Outcome ,General Medicine ,medicine.disease ,Pregnancy Complications ,Perinatal morbidity ,Pediatrics, Perinatology and Child Health ,Premature Birth ,Female ,business ,Body mass index - Abstract
UNLABELLED Maternal obesity is a major source of preventable perinatal morbidity, but studies of the relationship between obesity and preterm birth have been inconsistent. This review looks at two major studies covering just under 3.5 million births, from California, USA, and Sweden. CONCLUSION Inconsistent findings in previous studies appear to stem from the complex relationship between obesity and preterm birth. Initiatives to decrease maternal obesity represent an important strategy in reducing preterm birth.
- Published
- 2014
246. Contents Vol. 106, 2014
- Author
-
Anne Chauty-Frondas, Joseph Ting, Amuchou Soraisham, Sukyoung Park, Sophie Soudée, Annemieke J. Brouwer, Afif El-Khuffash, Cathy Hammerman, Amish Jain, Michael J. Kaplan, Vrinda Nair, Manon J.N.L. Benders, Géraldine Gascoin, Dany E. Weisz, Hendrik J. Vreman, Damir Mohamed, Zang-Hee Cho, Odile Becquet, Marie Halbwachs, So Yeon Shim, Hassan M. Yaish, Paul Renbaum, Satz Mengensatzproduktion, Valérie Rouger, Robert D. Christensen, Jean-Baptiste Muller, Jean-Christophe Rozé, Mira Chung, Hye-Jin Jeong, Cyril Flamant, Linda S. de Vries, David K. Stevenson, Valérie Biran, Roberto Nussenzveig, Floris Groenendaal, C. Farnoux, Josef Neu, Archana M. Agarwal, Corinne Alberti, Olivier Baud, Ze D. Jiang, Li L. Ping, Dong Woo Son, Ronald J. Wong, Bernard Branger, Lucie Vuillemin, Patrick J. McNamara, Josef T. Prchal, Druckerei Stückle, and Prakash Loganathan
- Subjects
Pediatrics ,medicine.medical_specialty ,Traditional medicine ,business.industry ,Pediatrics, Perinatology and Child Health ,medicine ,business ,Developmental Biology - Published
- 2014
247. The ethics and practice of neonatal resuscitation at the limits of viability: an international perspective
- Author
-
Jean-Michel Hascoet, Mikael Norman, Margot van de Bor, David K. Stevenson, Apostolos Papageorgiou, Thor Willy Ruud Hansen, Jonathan M. Fanaroff, Eric S. Shinwell, Malcolm I. Levene, Case Western Reserve University [Cleveland], Service de Médecine Néonatale [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Développement, Adaptation et Handicap. Régulations cardio-respiratoires et de la motricité (DevAH), Université de Lorraine (UL), Oslo University Hospital [Oslo], Division of Pediatrics and Child Health [Leeds], University of Leeds, Karolinska Institutet [Stockholm], Jewish General Hospital, Bar-Ilan University [Israël], Vrije universiteit = Free university of Amsterdam [Amsterdam] (VU), Stanford University, Health & Life, and VU University Amsterdam
- Subjects
medicine.medical_specialty ,Resuscitation ,Internationality ,SDG 16 - Peace ,education ,Nursing ,medicine ,Humans ,Neonatology ,Comfort care ,Intensive care medicine ,ComputingMilieux_MISCELLANEOUS ,business.industry ,Delivery room ,Perspective (graphical) ,SDG 16 - Peace, Justice and Strong Institutions ,Infant, Newborn ,Foundation (evidence) ,General Medicine ,humanities ,Justice and Strong Institutions ,3. Good health ,Infant, Extremely Premature ,Pediatrics, Perinatology and Child Health ,Intensive Care, Neonatal ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,Neonatal resuscitation - Abstract
Premature infants at the limits of viability raise difficult ethical, legal, social and economic questions. Neonatologists attending an international Collegium were surveyed about delivery room behaviour, and the approach taken by selected countries practicing 'modern' medicine was explored. Conclusion There were strong preferences for comfort care at 22 weeks and full resuscitation at 24 weeks. Resuscitation was a grey area at 23 weeks. Cultural, social and legal factors also had a considerable impact on decision-making. ©2014 Foundation Acta Pædiatrica. Published by John Wiley & Sons Ltd.
- Published
- 2014
248. Neonatal physiological correlates of near-term brain development on MRI and DTI in very-low-birth-weight preterm infants
- Author
-
Susan R. Hintz, Katelyn Cahill-Rowley, Jessica Rose, Ximena Stecher Guzman, David K. Stevenson, Naama Barnea-Goraly, and Rachel Vassar
- Subjects
Male ,Pediatrics ,Internal capsule ,Corpus callosum ,ALIC, anterior limb of the internal capsule ,Gastroenterology ,lcsh:RC346-429 ,0302 clinical medicine ,Infant, Very Low Birth Weight ,FA, fractional anisotropy ,medicine.diagnostic_test ,Gestational age ,Brain ,Retinopathy of prematurity ,Magnetic Resonance Imaging ,Brain development ,3. Good health ,Diffusion tensor imaging ,Neurology ,Necrotizing enterocolitis ,lcsh:R858-859.7 ,Female ,medicine.symptom ,Psychology ,IC, internal capsule ,Infant, Premature ,MRI ,medicine.medical_specialty ,Cognitive Neuroscience ,CC, corpus callosum ,lcsh:Computer applications to medicine. Medical informatics ,Article ,03 medical and health sciences ,030225 pediatrics ,Internal medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,lcsh:Neurology. Diseases of the nervous system ,MD, mean diffusivity ,PMA, post-menstrual age ,Infant, Newborn ,Infant ,Preterm infants ,Magnetic resonance imaging ,medicine.disease ,Low birth weight ,Cross-Sectional Studies ,Bronchopulmonary dysplasia ,Risk factors ,VLBW, very-low-birth-weight ,PLIC, posterior limb of the internal capsule ,GloP, globus pallidus ,White matter microstructure ,Neurology (clinical) ,DTI, diffusion tensor imaging ,GA, gestational age ,030217 neurology & neurosurgery - Abstract
Structural brain abnormalities identified at near-term age have been recognized as potential predictors of neurodevelopment in children born preterm. The aim of this study was to examine the relationship between neonatal physiological risk factors and early brain structure in very-low-birth-weight (VLBW) preterm infants using structural MRI and diffusion tensor imaging (DTI) at near-term age. Structural brain MRI, diffusion-weighted scans, and neonatal physiological risk factors were analyzed in a cross-sectional sample of 102 VLBW preterm infants (BW ≤ 1500 g, gestational age (GA) ≤ 32 weeks), who were admitted to the Lucile Packard Children's Hospital, Stanford NICU and recruited to participate prior to routine near-term brain MRI conducted at 36.6 ± 1.8 weeks postmenstrual age (PMA) from 2010 to 2011; 66/102 also underwent a diffusion-weighted scan. Brain abnormalities were assessed qualitatively on structural MRI, and white matter (WM) microstructure was analyzed quantitatively on DTI in six subcortical regions defined by DiffeoMap neonatal brain atlas. Specific regions of interest included the genu and splenium of the corpus callosum, anterior and posterior limbs of the internal capsule, the thalamus, and the globus pallidus. Regional fractional anisotropy (FA) and mean diffusivity (MD) were calculated using DTI data and examined in relation to neonatal physiological risk factors including gestational age (GA), bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP), and sepsis, as well as serum levels of C-reactive protein (CRP), glucose, albumin, and total bilirubin. Brain abnormalities were observed on structural MRI in 38/102 infants including 35% of females and 40% of males. Infants with brain abnormalities observed on MRI had higher incidence of BPD (42% vs. 25%) and sepsis (21% vs. 6%) and higher mean and peak serum CRP levels, respectively, (0.64 vs. 0.34 mg/dL, p = .008; 1.57 vs. 0.67 mg/dL, p= .006) compared to those without. The number of signal abnormalities observed on structural MRI correlated to mean and peak CRP (rho = .316, p = .002; rho = .318, p= .002). The number of signal abnormalities observed on MRI correlated with thalamus MD (left: r= .382, p= .002; right: r= .400, p= .001), controlling for PMA-at-scan. Thalamus WM microstructure demonstrated the strongest associations with neonatal risk factors. Higher thalamus MD on the left and right, respectively, was associated with lower GA (r = −.322, p = .009; r= −.381, p= .002), lower mean albumin (r = −.276, p= .029; r= −.385, p= .002), and lower mean bilirubin (r = −.293, p= .020; r= −.337 p= .007). Results suggest that at near-term age, thalamus WM microstructure may be particularly vulnerable to certain neonatal risk factors. Interactions between albumin, bilirubin, phototherapy, and brain development warrant further investigation. Identification of physiological risk factors associated with selective vulnerability of certain brain regions at near-term age may clarify the etiology of neurodevelopmental impairment and inform neuroprotective treatment for VLBW preterm infants., Highlights • Biomarkers of inflammation in preterm infants correlated with brain abnormalities detected on near-term structural MRI. • Biomarkers of inflammation in preterm infants correlated with near-term WM microstructure assessed on DTI. • Signal abnormalities observed on near-term structural MRI correlated with increased thalamus MD.
- Published
- 2014
249. Heme Oxygenase-1 Promoter Polymorphisms and Neonatal Jaundice
- Author
-
Michael Kaplan, Ronald J. Wong, Hendrik J. Vreman, Paul Renbaum, David K. Stevenson, and Cathy Hammerman
- Subjects
Bilirubin ,Promoter ,Biology ,Molecular biology ,Heme oxygenase ,chemistry.chemical_compound ,chemistry ,Pediatrics, Perinatology and Child Health ,Genotype ,Carboxyhemoglobin ,Gene expression ,Heme ,Gene ,Developmental Biology - Abstract
Background: Heme oxygenase (HO) is the initial, rate-limiting enzyme in the conversion of heme to bilirubin. Dinucleotide (GT)n repeat length in the promoter region of the encoding gene modulates transcription: shorter alleles, in contrast with longer allele counterparts, are associated with greater gene expression and should result in increased heme catabolism. Objective: We compared the rates of heme catabolism and plasma total bilirubin (TB) between HO-1 promoter genotypes of varying (GT)n repeat lengths in glucose-6-phosphate dehydrogenase (G6PD)-normal and -deficient neonates. Methods:HO-1 promoter length was determined from genomic DNA from previous studies by size discrimination of fluorescently-labeled PCR products with capillary electrophoresis. Sizing was confirmed by sequencing homozygote samples. Alleles were categorized as: short (≤24 GT repeats), medium (25-33 GT repeats), and long (≥34 GT repeats). Previously determined values for blood carboxyhemoglobin, corrected for inspired carbon monoxide (COHbc), and TB were used to determine the rate of heme catabolism and 3rd day TB values for each HO-1 promoter length genotype, respectively. G6PD Mediterranean was determined by PCR analysis. Results: Neither COHbc nor TB values were significantly different between various HO-1 promoter genotypes for either G6PD-normal or -deficient neonates. Conclusions: In the steady state, HO-1 promoter genotypes, based on the length of (GT)n repeats, do not modulate heme catabolism or 3rd day TB values in either G6PD-normal or -deficient neonates.
- Published
- 2014
250. Patterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort
- Author
-
Charles R. Rosenfeld, Marcia Worley Mersmann, Edward F. Bell, Kristin M. Zaterka-Baxter, Kristi L. Watterberg, Alicia Guzman, Lucy Miller, Ruth Everett-Thomas, James P. Kiley, Faithe Hamer, Marie G. Gantz, M. Bethany Ball, Beverly Foley Harris, Karen J. Johnson, Conra Backstrom Lacy, Susan Barnett, Kate Bridges, Sarah Lillie, Pat Cervone, Laura Grau, Gaynelle Hensley, Kerry Wilder, Richard A. Ehrenkranz, Ellen C. Hale, Maynard Rasmussen, David K. Stevenson, Kristen Angela, Betty K. Hastings, Kurt Schibler, Angelita M. Hensman, Nancy S. Newman, Amy K. Hutchinson, Kim Francis, Nancy Peters, Mary Anne Berberich, Dennis Wallace, Beena G. Sood, Brenda H. Morris, Michele C. Walsh, Michael S. Caplan, John A. Widness, Harris C. Jacobs, Dawn Andrews, Krisa P. Van Meurs, Stephanie Wilson Archer, Mary Johnson, Ivan D. Frantz, Nathan Morris, Sarah Martin, Alan H. Jobe, Diana M. Vasil, T. Michael O'Shea, Shahnaz Duara, Carolyn M. Petrie Huitema, Ronald N. Goldberg, Dale L. Phelps, Margaret M. Crawford, Sharon F. Freedman, Shirley S. Cosby, Jeanette O'Donnell Auman, C. Michael Cotten, Ellen Nylen, Monica V. Collins, Elizabeth Billian, Patricia Gettner, Kathleen A. Kennedy, Richard A. Polin, Waldemar A. Carlo, Avroy A. Fanaroff, Roger G. Faix, Gary David Markowitz, James A. Lemons, Katherine A. Foy, Abbot R. Laptook, James Allen, Brenda B. Poindexter, Kimberly A. Fisher, Bradley A. Yoder, David K. Wallace, Seetha Shankaran, Walid A. Salhab, Brenda L. MacKinnon, JoAnn Poulsen, Kimberlee Weaver-Lewis, Susie Buchter, Karen A. Osborne, Nancy A. Miller, Jill Burnett, Arlene Zadell, William Oh, Sharon L. Wright, Juliann M. Di Fiore, Kathy J. Auten, Namasivayam Ambalavanan, Vineet Bhandari, Barbara Alexander, Renee Bridge, Melinda S. Proud, Holly L. Mincey, Julie Rohr, Janet Taft, Cynthia Spencer, Cathy Grisby, Robin K. Ohls, Bonnie S. Siner, Monica Konstantino, Abhik Das, Patti L. Pierce Tate, Paul Wozniak, Melissa Martin, Linda J. Reubens, Barbara J. Stoll, Jennifer J. Jensen, Hong Li, Anthony J. Piazza, David P. Carlton, Wade Rich, Dianne E. Herron, Amanda R. Irene, Vivien Phillips, Georgia E. McDavid, Jody Hessling, Araceli Solis, Carol J. Blaisdell, Erica Burnell, Nirupama Laroia, Richard J. Martin, Kathy Arnell, Rebecca Bara, Clarence Demetrio, John M. Fiascone, Jonathan M. Klein, Anna E. Lis, Melissa H. Lepps, Vivek Narendran, Anne Furey, Jon E. Tyson, Edward F. Donovan, Dan Gingras, James W. Pickett, Rosemary D. Higgins, Leslie Dawn Wilson, Pablo J. Sánchez, Dorothy B. Gail, and Neil N. Finer
- Subjects
Male ,medicine.medical_specialty ,Pediatrics ,medicine.medical_treatment ,Positive pressure ,Gestational Age ,Infant, Premature, Diseases ,Article ,Hypoxemia ,Cohort Studies ,03 medical and health sciences ,Surface-Active Agents ,0302 clinical medicine ,030225 pediatrics ,Internal medicine ,Medicine ,Humans ,030212 general & internal medicine ,Continuous positive airway pressure ,Hypoxia ,Oxygen saturation ,Survival rate ,Continuous Positive Airway Pressure ,business.industry ,Hazard ratio ,Infant, Newborn ,Oxygen Inhalation Therapy ,Infant ,Pulmonary Surfactants ,Oxygenation ,medicine.disease ,Oxygen ,Survival Rate ,Infant, Extremely Premature ,Pediatrics, Perinatology and Child Health ,Infant, Small for Gestational Age ,Cardiology ,Small for gestational age ,Female ,medicine.symptom ,business - Abstract
Objective To characterize actual achieved patterns of oxygenation in infants born appropriate vs small for gestational age (SGA) randomized to a lower (85-89%) vs higher (91%-95%) oxygen saturation target in the Surfactant Positive Pressure and Oxygen Trial. To determine the association between achieved oxygen saturation levels and survival in infants born appropriate vs SGA enrolled in the Surfactant Positive Pressure and Oxygen Trial. Study design Median oxygen saturation and intermittent hypoxemia events ( 0/7 -27 6/7 weeks of gestation while receiving supplemental oxygen during the first 3 days of life. Results Lower target infants who were small for gestational age had the lowest oxygen saturation and highest incidence of intermittent hypoxemia during the first 3 days of life. The lowest quartile of oxygen saturation (≤92%) during the first 3 days of life was associated with lower 90-day survival for both infants born appropriate and SGA. An increased incidence of intermittent hypoxemia events during the first 3 days of life was associated with lower 90-day survival only in infants born SGA. Conclusion Lower achieved oxygen saturation during the first 3 days of life was associated with lower 90-day survival in extremely preterm infants. Infants born SGA had enhanced vulnerability to lower oxygen saturation targets as evidenced by lower achieved oxygen saturation and an association between increased intermittent hypoxemia events and lower survival. Trial registration ClinicalTrials.gov: NCT00233324.
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.